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Abstract 
Physical rehabilitation programs are often prescribed in an effort to maintain range of 
motion, and to adapt strategies for managing the debilitating symptoms of Parkinson disease 
(PD) in everyday life. An emerging trend to overcome the limitations of traditional 
rehabilitation is the use of virtual reality technologies. The goal of the present study was to 
determine the feasibility of augmented reality technology (IAR) in a rehabilitative setting. 
Three IAR environments were designed and a corresponding task was completed in each one. 
Not surprisingly, the control group generally performed better than the PD group on the 
tasks. All participants typically performed better in the real-world than the IAR environment. 
Additionally both the PD and control groups’ performances improved with repeated visits. 
The system was well-tolerated and important lessons are highlighted about future 
implementation of this rehabilitation approach (e.g., the need for a familiarization period to 
the system).  
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Chapter 1  
1 Introduction  
Parkinson disease (PD) is the second most common neurodegenerative disorder (after 
Alzheimer’s disease) and predominantly affects older people over 60 years of age. The 
cardinal diagnostic manifestations of the disease accepted by the UK Brain Bank Criteria 
are four major motor symptoms: resting tremor, rigidity, bradykinesia and postural 
instability along with asymmetry and response to Levodopa therapy (Hughes, Daniel, 
Kilford, & Lees, 1992). These motor symptoms are thought to be due in part to the 
degeneration of pigmented dopaminergic neurons in the ventrolateral portion of the 
substantia nigra pars compacta within the midbrain. Nonmotor symptoms such as 
depression, apathy, anxiety, hallucinations and psychosis may emerge at different stages 
of disease and exhibit complex relationships with motor symptoms. The major cause of 
disability in PD is impaired mobility (Wood, Bilclugh, Bowron & Walker, 2002), or the 
ability to move safely in a variety of environments in order to accomplish functional tasks 
(Patla & Shumway-Cook, 1998).  
This thesis will present ideas about the use of immersive augmented reality (IAR) 
in a rehabilitation setting for people living with PD.  In this chapter, an overview of PD 
will be presented in order to provide a context for those not familiar with aspects the 
disease relevant for the ensuing discussion throughout the thesis.  
1.1 Physical, Cognitive, and Quality of Life Symptoms in 
Parkinson disease 
People living with PD have several prominent symptoms that are possible therapeutic 
targets for exercise and physical rehabilitation programs. These include physical 
symptoms (including balance and gait issues as well as the cardinal motor symptoms), 
cognitive impairment, and quality of life issues.  
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1.1.1 Physical Symptoms 
PD is a relatively common neurodegenerative disease where dopamine-producing 
neurons in the substantia nigra are progressively lost resulting in a neurotransmitter 
imbalance (Greenfield & Bosanquet, 1953). This occurs largely unnoticed by the 
individual until approximately 80% of neurons have died at which point physical 
symptoms become evident such as motor skill, cognitive and autonomic dysfunction 
(Hughes, Daniel, Blankson, & Lees, 1992). Locomotor abilities including gait are 
prominently affected even in early stage disease. Step length is reduced and becomes 
asymmetrical, walking speed diminishes, and gait initiation becomes effortful and 
difficult (Morris, 2006; Jankovic, Nutt & Sudarsky, 2001). Resting tremor, rigidity, and 
in late disease postural instability and falling are also common physical symptoms of PD. 
These physical impairments are associated with decreased mobility. Mobility will be 
defined here as the ability to move freely within and between various environments in 
order to actively participate in the community. Safety becomes compromised while 
completing ADLs such as walking and turning around the home or community, 
transferring from lying to sitting or sitting to standing, and more complex tasks such as 
house chores or preparing a meal (Stack, Ashburn, & Jupp, 2006). The ability to perform 
complex functional tasks is compromised while the ability to perform simple movements 
is preserved. Simple movements are controlled by frontal, cerebellar, and brain stem 
regions as opposed to the coordination and timing operations controlled by the basal 
ganglia (Shibasaki, 2012; Seitz & Roland, 1992); and these regions are not directly 
affected in early stages of PD. Additionally, muscle tone and strength are preserved 
suggesting that the difficulty in completing tasks is not purely biomechanical and that 
there is likely a large role of higher order processing that may be impaired. These activity 
limitations restrict participation in societal roles related to work, family, civic life and 
leisure (Morris, 2005).  
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1.1.2 Cognitive Symptoms 
Although PD is typically classified as a motor disorder, cognitive changes occur at all 
stages of disease (Bassett, 2005; Stocchi & Brusa, 2000). Longitudinal studies have 
identified cognitive deficits in many areas but particularly in language, visuospatial 
functioning, long-term memory, and executive functioning, they are greater in PD than 
would be expected in a typically aging population (Locasico, Corkin,  & Growdon, 
2003). There is ongoing debate about the number of people with PD who will advance 
from mild cognitive impairment to dementia, however a review of prevalence studies 
suggests that 29% of patients are diagnosed with PD-related dementia (Rajput, 1992).  
The frontal lobes are thought to underlie many executive processes and therefore these 
types of impairments in PD are attributed to frontal dysfunction. However unlike frontal 
lobe injury patients who are unable to adapt responses to environmental change, the 
issues in PD are characterized by difficulty in “filtering” or ignoring unnecessary and 
irrelevant environmental stimuli (Menza & Dobkin, 2006). During divided attention tasks 
PD patients have difficulty ignoring distractors and appropriately allocating resources 
(Richard, 2005). 
Even in early disease, a subtle decline in cognitive ability can have a substantial impact 
on daily functioning and quality of life. Younger patients who engage in cognitively 
challenging activities or employment are more at risk for drastic life changes. However 
smaller scale memory lapses can result in serious safety threats (e.g. forgetting to turn off 
the stove or lock the door). Another area of concern is how cognitive impairment may 
affect fitness to drive a vehicle (Devos, Vandenberghe, Nieuwboer, et al, 2007; Stolwyk, 
Charlton, Triggs, et al, 2006). Patients often perceive the ability to drive a major 
determinant of their independence.  
A growing body of research is investigating how cognitive disturbances are also 
implicated in gait changes (Hausdorff, Yogev, Springer, Simon, & Giladi, 2005; Marqui, 
Moore, Howieson, et al., 2002; Verghese, Lipton, Hall, Kuslansky, Katz, & Buschke, 
2002; Hausdorff, Schweiger, Herman, Yogev-Seligmann, & Giladi, 2008). Declines in 
attention, psychomotor processing, problem solving, and awareness of self and 
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surroundings have the biggest impact on postural control, gait and falls (Alexander & 
Hausdorff, 2008). These are common deficits experienced by people with PD, raising 
concern about their ability to maintain safe ambulation across disease.  
Evidently, cognitive issues can have a large impact on mobility. This is in part due to the 
attentional demands required to safely navigate the community by motor vehicle or other 
means, and partly due to the cognitive consequences on gait patterns resulting in 
increased fall risk.  
1.1.3 Quality of Life 
Motor and cognitive changes are strongly associated with instability, falls, and fear of 
future falls. These symptoms often lead to self-imposed restrictions of daily activities, 
which contribute to reduced mobility, result in a further loss of independence and deprive 
patients of social contacts, leading to isolation, depression, and overall reduced quality of 
life (Rahman, Griffin, Quinn, & Jahanshahi, 2008; Forsaa, Larsen, Wentzel-Larsen, 
Herlofson, & Alves, 2008). Some factors that contribute to a lower quality of life are the 
rate of disease progression, motor fluctuations and dyskinesias (Marras, Lang, Krahn, 
Tomlinson & Naglie, 2004).  
Other challenges encountered by people living with PD include fatigue (Herlofesen & 
Larsen, 2003), changing social roles and identity, and changes in existing relationships 
(Habermann, 1996). Experiences with affective disorders, such as depression or anxiety, 
psychosis, sleep disorders, and lack of independence can also seriously influence quality 
of life. (Schrag, Jahanshahi, & Quinn, 2000; Symister & Friend, 2003).  
Interestingly, a study conducted in Israel reported that people living with PD felt 
symptoms other than the cardinal motor signs had the greatest effect on their quality of 
life. Over half of the 39 patients without PD perceived their difficulty with mental 
changes, activity loss, psychosocial difficulties such as anxiety and depression, and 
nonspecific symptoms such as constipation and insomnia, and major motor symptoms 
were much less frequently reported (Abudi, Bar-Tal, Ziv, & Fish, 1997).  
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1.2 Pharmacological Treatment of Parkinson disease 
Current treatment of PD is symptomatic and does not significantly modify disease 
progression. The gold standard for treatment of PD is L-dihydroxyphenylalanine 
(Levodopa), (Yahr, Duvoisin, Schear, Barrett & Hoehn, 1969) combined with a 
peripheral decarboxylase inhibitor to inhibit peripheral bioconversion of Levodopa to 
dopamine, thereby reducing dopaminergic side-effects and improving availability of 
Levodopa to the brain (Lees, Katzenschlager, Head, & Ben-Shlomo, 2001; Macphee & 
Stewart, 2012). More recent advancements in medical symptomatic treatment have 
focused on Levodopa treatments that do not require such bioconversion and target the 
dopamine receptors directly, namely dopamine agonists. Enzyme blockers that reduce the 
breakdown of dopamine include monoamine oxidase (MAO) B inhibitors and catechol-
O-methyltransferase inhibitors (COMT) inhibitors.  
Agonists act directly on postsynaptic dopamine receptors. Dopamine agonists may be 
prescribed as monotherapy in early disease to delay motor complications from Levodopa 
therapy (Rascol, Brooks, Korczyn, DeDeyn, Clarke, & Lang, 2000; Parkinson Study 
Group, 2000; Rinne & PKDS009 Collaborative Study Group, 1999). Additionally, 
agonists may prolong on time, reduce off time and also delay time to dyskinesia in 
patients already taking Levodopa compared to increasing the Levodopa dose alone 
(Watts, Lyons, Pahwa, Sethi, Stearn, Hauser, et al., 2010).  This is known as the 
Levodopa sparing effect. 
In the basal ganglia, dopamine is predominantly metabolized by MAO-B and COMT. 
MAO-B inhibitors such as Rasagiline may also be used as monotherapy in early disease 
(Parkinson Study Group, 2002) and also as an adjunct to Levodopa in order to decrease 
off-time between doses (Parkinson Study Group, 2005; Rascol, Brooks, Melamed, Oertel, 
Poewe, Stocchi, et al., 2005). 
The addition of decarboxylase inhibitors to the levodopa dose shifts peripheral dopamine 
metabolism more to COMT. Peripheral and central COMT inhibitors reduce levodopa 
metabolism by this alternative pathway, allowing more to reach the brain thereby 
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decreasing motor fluctuations, wearing off, and increasing the amount of daily on-time 
(Nutt, Woodward, Beckner, Stone, Berggren, Carter, et al., 1994).   
Anticholinergic drugs are the oldest drug-class to be used in PD management and are 
typically used to treat tremor.  Finally, amantadine may also be used in combination with 
levodopa to treat dyskinesias. Amantadine has been shown to be a weak, non-competitive 
NMDA receptor antagonist, however its precise mechanism of action is not well known.  
There are evidently many pharmacological treatment options available for PD that should 
theoretically provide great motor function improvement. Although dramatic motor 
improvement is obtained, after a number of years of levodopa treatment, side effects such 
as motor fluctuations and dyskinesias become prominent and disabling. This brief review 
of drug therapy in PD management is intended to provide an understanding that 
pharmacotherapy in PD is extremely complicated and yet does not provide 100% 
alleviation of symptoms. Furthermore, it provides validation for investigating alternative 
symptom management strategies to be combined with drug options. It is theoretically 
possible that the combination of non-pharmacological and pharmacological strategies 
would together allow better control of motor symptoms and enhance the ability to 
perform activities of daily living. This could lead to maintenance of lower medication 
dosage thereby reducing the side effects discussed above. 
1.3 Summary of Introduction  
Pharmacological	  interventions	  are	  in	  place	  to	  effectively	  treat	  many	  motor	  symptoms	  of	  PD.	  However	  as	  the	  disease	  progresses,	  it	  becomes	  more	  difficult	  to	  balance	  drug	  therapy	  benefits	  with	  side	  effects.	  Motor	  symptoms	  of	  PD	  cause	  debilitating	  decreases	  in	  mobility,	  and	  physical	  rehabilitation	  including	  physical	  and	  occupational	  therapies	  as	  well	  as	  alternative	  approaches	  may	  improve	  mobility	  functioning.	  It	  is	  possible	  that	  if	  implemented	  early,	  these	  alternative	  approaches	  could	  target	  specific	  components	  of	  disability	  that	  are	  important	  to	  the	  performance	  of	  activities	  of	  daily	  living.	  In	  addition,	  these	  interventions	  could	  also	  reduce	  the	  need	  for	  pharmacotherapy	  thereby	  reducing	  the	  drug	  dependent	  side	  effects.	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Current	  physical	  and	  occupational	  therapy	  treatment	  approaches	  have	  limited	  customizability,	  scalability,	  and/or	  functional	  relevance.	  Investigations	  into	  alternative	  methods	  of	  physical	  rehabilitation	  are	  required	  that	  provide	  a	  motor-­‐cognitive	  challenge	  scalable	  across	  all	  stages	  of	  disease.	  Furthermore,	  physical	  rehabilitation	  does	  not	  address	  the	  cognitive	  deficits	  inherent	  in	  PD	  progression.	  Rehabilitation	  must	  focus	  on	  more	  than	  just	  the	  physical	  disability	  of	  PD	  and	  rather	  address	  the	  interaction	  between	  motor	  and	  cognitive	  deficits	  together.	  	  
This introduction has served to present the basic facts about Parkinson disease motor 
dysfunction, the complications and complexities of pharmacological management, how 
physical rehabilitation options may assist in symptom management, and finally the 
limitations of existing rehabilitation approaches. This information is vital to the reader in 
order to appreciate the discussion that follows about the potential for immersive 
augmented reality in rehabilitation for PD.  
The second chapter will discuss related work and lead to the rationale of this project. 
Reasoning for including PD as the target population is provided as well as rationale for 
why IAR may be suitable for rehabilitation as it relates to immersiveness and 
performance.  
The third chapter describes the method employed in this study with respect to the 
hardware, software, and tasks used.  
The fourth chapter describes the result of the software programming, and performance of 
the participants on all tasks.  
The fifth chapter presents a discussion about the viability of an IAR system in a 
rehabilitation setting. A compilation of final conclusions, limitations of the study, future 
directions are discussed.  	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Chapter 2  
2 Background  
The aim of this chapter is to describe PD from the perspective of how rehabilitation may 
aid in the management of particular symptoms including the physical and cognitive 
symptoms, and overall quality of life will first be discussed. This will be followed by a 
discussion of the current pharmacological treatments to demonstrate the limited options 
and to begin to present the complexities of managing this disease. Rehabilitative 
interventions such as physical therapy and their role in PD treatment will be positioned to 
provide some rationale about the inclusion of physical rehabilitation in the treatment 
regime. Finally the limitations of traditional physiotherapy specifically in the PD 
population will be highlighted and more recent work that has been done using alternative 
methods of delivery including virtual reality will also be presented. The objective is to 
identify the rehabilitation needs unique to the PD population and hence why a non-
standard rehabilitation paradigm may be beneficial. Such a framework then justifies the 
rationale for investigating novel rehabilitation techniques for PD such as IAR.  
2.1 Physical Rehabilitation Options in Parkinson disease 
Management 
Parkinson	  disease	  is	  the	  hallmark	  of	  neurodegenerative	  mobility	  dysfunction.	  Typical	  motor	  deficits	  include	  bradykinesia,	  rigidity,	  tremor	  and	  akinesia.	  In	  addition,	  postural	  instability	  and	  compromised	  balance	  are	  serious	  and	  common	  symptoms	  among	  patients	  (Benatru	  et	  al	  2008).	  However	  PD	  is	  not	  purely	  a	  motor	  disease.	  Mild	  cognitive	  impairment	  is	  a	  well-­‐recognized	  feature	  of	  early	  PD,	  and	  will	  often	  progress	  to	  dementia	  by	  late-­‐stage	  disease.	  Cognitive	  function	  has	  been	  shown	  to	  be	  an	  important	  predictor	  of	  quality	  of	  life	  (Karlsen	  et	  al	  1998;	  Schrag	  et	  al	  2000)	  and	  therefore	  has	  been	  subjected	  to	  much	  investigation.	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Despite	  optimal	  pharmacological	  treatment,	  motor	  functions	  continue	  to	  deteriorate	  leading	  to	  impaired	  mobility	  (defined	  as	  the	  ability	  to	  navigate	  and	  function	  in	  a	  variety	  of	  environments),	  self-­‐care,	  and	  participation,	  all	  of	  which	  contribute	  to	  limitations	  of	  daily	  living	  (Ransmayr,	  2011).	  Rehabilitative	  therapy	  interventions	  can	  be	  employed	  at	  any	  stage	  as	  an	  adjunct	  to	  levodopa	  therapy	  to	  help	  manage	  some	  of	  the	  motor	  symptoms	  and	  improve	  quality	  of	  life.	  	  
2.1.1 Physical Therapy 
The	  most	  widely	  used	  form	  of	  allied	  health	  care	  for	  PD	  is	  physical	  therapy	  (Nijkrake,	  Bloehm,	  Keus,	  &	  Mulleners,	  2006).	  The	  goal	  of	  physical	  therapy	  is	  to	  address	  specific	  physical	  issues	  including	  gait	  dysfunction,	  diminished	  control	  of	  physical	  capacity	  (i.e.	  strength	  and	  endurance),	  postural	  instability,	  and	  poor	  balance	  (Keus,	  Bloehm,	  Verbaan,	  et	  al.,	  2004).	  	  Together,	  treatment	  of	  these	  limitations	  may	  improve	  overall	  mobility	  including	  social	  and	  activity	  participation	  as	  well	  as	  activities	  of	  daily	  living.	  There	  have	  been	  some	  investigations	  into	  gait	  training	  with	  treadmills	  to	  improve	  gait	  parameters	  in	  PD.	  Findings	  suggest	  that	  treadmill	  training	  can	  reduce	  gait	  variability	  (Frankel-­‐Toledo,	  Giladi,	  Perets,	  et	  al.,	  2005)	  as	  well	  as	  improve	  walking	  speed	  and	  stride	  (Pohl,	  Rockstroh,	  Ruckriem,	  et	  al.,	  2003).	  However	  there	  has	  been	  insufficient	  evaluation	  of	  transferability	  of	  these	  improvements	  to	  activities	  of	  daily	  living	  and	  reports	  vary	  with	  regards	  to	  the	  duration	  of	  sustained	  improvement	  (Mehrholz,	  Friis,	  Kugler,	  et	  al.,	  2010	  for	  review).	  	  Other	  physical	  therapy	  strategies	  include	  balance	  training	  and	  high	  intensity	  resistance	  training.	  One	  study	  noted	  improved	  balance	  function	  four	  weeks	  after	  the	  intervention	  (Hirsch,	  Toole,	  Maitland,	  &	  Rider,	  2003).	  Muscle	  stretching,	  reinforced	  patterns	  of	  movement,	  and	  active	  muscle	  contraction	  have	  also	  been	  implemented	  to	  facilitate	  proprioceptive	  neuromuscular	  function	  (Chandler	  &	  Plant,	  1999;	  Comella,	  Stebbins,	  Brown-­‐Toms,	  &	  Goetz,	  1994).	  Overall,	  there	  has	  been	  inadequate	  reporting	  of	  sustained,	  measurable	  outcome	  benefits	  after	  receiving	  physical	  therapy.	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A	  limitation	  of	  traditional	  physical	  therapy	  treatments	  is	  that	  they	  are	  largely	  not	  task-­‐specific	  or	  goal-­‐oriented,	  making	  the	  transfer	  of	  skill	  or	  physical	  improvement	  difficult	  to	  perceive.	  This	  may	  diminish	  the	  functional	  relevance	  of	  traditional	  physical	  therapy	  approaches	  and	  requires	  novel	  techniques	  that	  provide	  individualized	  functional	  relevance	  within	  the	  rehabilitation	  approach.	  	  
2.1.2 Occupational Therapy  
Occupational	  therapy	  involves	  therapeutic	  use	  of	  everyday	  functional	  activities	  for	  enhancing	  participation	  (Rao,	  2010).	  Occupational	  therapy	  focuses	  on	  training	  motor	  skills	  such	  as	  balance,	  mobility,	  transfers	  and	  object	  manipulation	  and	  methods	  may	  overlap	  with	  those	  of	  physical	  therapy	  (Gutman,	  Mortera,	  Hinojasa,	  &	  Kramer,	  2007).	  	  	  Occupational	  therapy	  approaches	  include	  task-­‐related	  training	  where	  functional	  tasks	  are	  practiced.	  Studies	  report	  improvement	  in	  performance	  of	  activities	  of	  daily	  living,	  however	  do	  not	  address	  improvement	  beyond	  therapy	  (Rao,	  2010).	  A	  pilot	  study	  (Clarke,	  Furmston,	  Morgan,	  Patel,	  Sackley,	  Walker,	  et	  al.,	  2009)	  implementing	  at-­‐home	  occupational	  therapy	  techniques	  including	  task-­‐specific	  practice,	  reducing	  complexity/demands	  of	  a	  task,	  and/or	  altering	  the	  environment	  with	  the	  addition	  of	  aids	  and	  adaptations.	  The	  authors	  stated	  their	  intervention	  was	  well	  tolerated	  by	  PD	  patients	  and	  that	  there	  was	  an	  improvement	  in	  quality	  of	  life	  scores	  (Parkinson	  Disease	  Quality	  of	  life	  Questionnaire-­‐39)	  and	  also	  on	  activities	  of	  daily	  living	  scale	  (Nottingham	  Extended	  Activities	  of	  Daily	  Living	  scale).	  	  A	  second	  approach	  in	  occupational	  therapy	  is	  the	  addition	  of	  auditory	  or	  visual	  cues	  to	  functional	  training.	  This	  approach	  assumes	  that	  external	  cueing	  would	  circumvent	  the	  impairment	  in	  production	  of	  internal	  cues.	  However,	  reports	  are	  mixed	  about	  the	  longevity	  of	  benefit	  of	  such	  cueing	  techniques	  beyond	  the	  duration	  of	  the	  therapeutic	  intervention.	  Marchese	  and	  colleagues	  (2000)	  were	  able	  to	  measure	  significant	  and	  lasting	  changes	  in	  the	  activities	  of	  daily	  living	  (ADL)	  and	  motor	  subsection	  scores	  of	  the	  Unified	  Parkinson	  Disease	  Rating	  Scale	  six	  weeks	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following	  a	  six	  week	  rehabilitation	  program	  with	  external	  sensory	  cues	  (Marchese,	  Diverio,	  Zucchi,	  Lentino,	  &	  Abbruzzese,	  2000).	  However,	  a	  much	  larger	  single-­‐blind	  randomised	  crossover	  trial	  with	  153	  participants	  saw	  no	  carryover	  effects	  in	  functional	  or	  quality	  of	  life	  domains	  after	  a	  3-­‐week	  home	  cueing	  program	  (Nieuboer,	  Kwakkel,	  Rochester,	  Jones,	  Weggen,	  Willems,	  et	  al.,	  2007).	  	  Despite	  reports	  from	  patients	  on	  the	  benefits	  of	  occupational	  therapy,	  there	  is	  inadequate	  literature	  to	  support	  any	  substantial	  benefit,	  and	  more	  randomized	  controlled	  trials	  are	  required	  to	  understand	  its	  applicability	  to	  PD.	  	  	  	  
2.1.3 Strength Training  
A	  study	  by	  Dibble	  and	  colleagues	  (2006)	  investigated	  the	  effect	  of	  high-­‐intensity	  resistance	  training	  on	  muscle	  hypertrophy	  and	  functional	  gains	  in	  a	  sample	  of	  19	  people	  with	  Parkinson	  disease.	  Ten	  participants	  received	  eccentric	  training	  (production	  of	  muscle	  force	  while	  the	  muscle	  is	  lengthening)	  and	  nine	  participants	  received	  “standard	  care”	  exercises	  three	  times	  per	  week	  over	  twelve	  weeks.	  All	  participants	  completed	  the	  standard	  care	  exercises	  including	  stretching,	  treadmill	  walking,	  cycling	  on	  a	  stationary	  bicycle,	  and	  weight	  lifting;	  while	  only	  the	  eccentric	  training	  group	  had	  additional	  training	  on	  an	  eccentric	  ergometer.	  The	  progression	  of	  eccentric	  work	  was	  gauged	  by	  ratings	  of	  perceived	  exertion	  (RPEs).	  	  Outcome	  measures	  included	  muscle	  cross-­‐sectional	  area	  determined	  by	  magnetic	  resonance	  imaging	  (MRI)	  of	  the	  quadriceps	  muscles,	  knee	  extension	  strength,	  and	  three	  functional	  mobility	  measures	  (6-­‐minute	  walk	  test,	  stair	  ascent	  and	  stair	  descent	  time).	  Comparisons	  between	  the	  two	  treatment	  groups	  were	  made	  to	  determine	  any	  benefit	  of	  the	  eccentric	  training.	  	  The	  eccentric	  training	  group	  demonstrated	  significantly	  greater	  gains	  in	  muscle	  volume	  of	  the	  quadriceps	  femoris	  muscle,	  but	  there	  were	  no	  significant	  differences	  in	  muscle	  strength.	  The	  eccentric	  group	  experienced	  greater	  improvements	  in	  the	  stair	  descent	  (p	  =	  0.007)	  and	  6-­‐minute	  walking	  (p	  =	  0.013)	  tasks	  than	  the	  standard-­‐care	  group,	  but	  not	  in	  the	  stair	  ascent	  measure	  (p=0.06).	  These	  results	  suggest	  that	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eccentric	  training	  may	  lead	  to	  muscle	  hypertrophy	  and	  strength	  gains	  that	  translate	  to	  functional	  improvements	  as	  well.	  	  Although	  these	  peripheral	  gains	  were	  seen	  with	  eccentric	  training,	  this	  study	  addressed	  only	  the	  peripheral	  musculoskeletal	  system	  and	  neglected	  the	  cognitive-­‐motor	  interaction	  prominently	  involved	  in	  motor	  control.	  	  A	  second	  study	  by	  Hass	  and	  colleagues	  (2012)	  investigated	  the	  effect	  of	  progressive	  resistance	  training	  on	  gait	  initiation	  in	  people	  with	  PD.	  Participants’	  gait	  initiation	  was	  biomechanically	  evaluated	  with	  force-­‐plates	  prior	  to	  and	  after	  a	  ten	  week	  progressive	  resistance	  training	  program.	  A	  non-­‐contact	  control	  group	  was	  also	  involved.	  The	  training	  program	  involved	  exercises	  such	  as	  seated	  leg-­‐press,	  knee	  extension,	  knee	  flexion,	  calf	  raises,	  and	  theraband	  ankle	  exercises.	  Weighted	  exercises	  were	  performed	  at	  70%	  of	  maximal	  knee-­‐extension	  and	  knee-­‐flexion	  one	  repetition	  strength,	  with	  the	  load	  progressively	  increasing	  over	  the	  course	  of	  the	  training	  program.	  The	  authors	  were	  interested	  in	  documenting	  changes	  in	  centre	  of	  pressure	  pattern	  changes	  and	  the	  initial	  stride	  (first	  two-­‐steps)	  length	  and	  velocity	  before	  and	  after	  the	  progressive	  resistance	  training.	  	  There	  was	  a	  significant	  difference	  in	  the	  posterior	  displacement	  of	  the	  centre	  of	  pressure	  (the	  primary	  mechanism	  for	  generating	  forward	  motion	  for	  gait	  initiation)	  in	  the	  resistance-­‐training	  group,	  and	  not	  in	  the	  control	  group.	  The	  authors	  claim	  that	  this	  program	  may	  improve	  anticipatory	  postural	  adjustments	  with	  respect	  to	  posterior	  movement	  of	  the	  centre	  of	  pressure.	  There	  was	  also	  a	  significant	  effect	  of	  the	  training	  program	  on	  initial	  stride	  velocity	  where	  the	  training	  group	  had	  a	  significant	  increase	  and	  the	  control	  group	  did	  not	  change,	  but	  there	  was	  no	  effect	  on	  stride	  length.	  This	  was	  interpreted	  as	  further	  support	  that	  improved	  strength	  may	  be	  associated	  with	  postural	  control	  during	  gait	  initiation	  in	  people	  with	  PD.	  Additionally	  the	  training	  group	  had	  significant	  increases	  in	  muscular	  strength	  for	  both	  knee	  extension	  and	  knee	  flexion	  exercises,	  however	  they	  do	  not	  address	  whether	  this	  is	  a	  result	  of	  increased	  central	  drive	  or	  improved	  peripheral	  muscular	  efficiency	  (Hass,	  Buckley,	  Pitsikoulis,	  &	  Barthelemy,	  2012).	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Although	  there	  was	  some	  change	  in	  the	  anticipatory	  postural	  adjustment	  patterns	  of	  the	  training	  group,	  it	  is	  difficult	  to	  extrapolate	  the	  benefits	  of	  strength	  training	  alone.	  Furthermore,	  there	  was	  no	  follow-­‐up	  study	  to	  determine	  if	  strength	  gains	  or	  the	  improved	  gait	  initiation	  patterns	  were	  maintained.	  	  Strength	  training	  may	  be	  beneficial	  for	  obtaining	  peripheral	  strength	  gains,	  however	  further	  benefits	  are	  difficult	  to	  rationalize	  and	  quantify.	  In	  order	  to	  achieve	  sustainable,	  transferable	  disease	  management,	  strength	  training	  should	  be	  incorporated	  with	  functional	  task	  training.	  Isolated	  strength	  training	  benefits	  may	  be	  lost	  quickly	  if	  the	  skills	  learned	  are	  not	  applicable	  to	  daily	  life.	  	  	  
2.1.4 Aerobic Training 
Aerobic	  training	  can	  be	  part	  of	  an	  exercise	  program	  for	  people	  with	  PD	  to	  address	  symptoms	  of	  weakness	  and	  fatigue.	  A	  study	  by	  Bergen	  and	  colleagues	  (2002)	  investigated	  the	  effect	  of	  a	  sixteen-­‐week	  aerobic	  training	  program	  on	  aerobic	  capacity	  (peak	  VO2)	  and	  movement	  initiation	  as	  a	  proxy	  for	  neuromuscular	  coordination.	  Four	  participants	  with	  PD	  completed	  the	  training	  program,	  and	  4	  other	  participants	  with	  PD	  who	  did	  not	  have	  an	  exercise	  intervention	  completed	  pre-­‐	  and	  post-­‐testing.	  This	  consisted	  of	  peak	  VO2	  testing	  on	  a	  cycle	  ergometer,	  and	  a	  series	  of	  movement	  initiation	  responses	  to	  visual	  and	  proprioceptive	  cues.	  The	  exercise	  program	  involved	  three	  sessions	  per	  week	  of	  cycling	  and	  treadmill	  walking	  at	  a	  target	  heart	  rate	  (60-­‐70%)	  for	  sixteen	  weeks	  and	  was	  followed	  by	  peak	  VO2	  and	  movement	  initiation	  post-­‐testing.	  	  The	  treatment	  group	  had	  a	  significant	  increase	  in	  peak	  VO2	  and	  a	  significant	  decrease	  in	  movement	  initiation	  time	  while	  the	  PD	  control	  group	  showed	  no	  change	  on	  either	  measure.	  Interestingly,	  there	  was	  a	  greater	  improvement	  in	  movement	  initiation	  time	  for	  “choice	  conditions”	  (21%	  versus	  8%	  for	  non-­‐choice)	  where	  the	  participants	  were	  able	  to	  choose	  a	  response	  and	  process	  information	  about	  the	  execution	  plan	  prior	  to	  making	  the	  movement.	  The	  authors	  propose	  that	  aerobic	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exercise	  may	  have	  improved	  the	  decision	  making	  process	  by	  enabling	  the	  PD	  participants	  to	  select	  the	  appropriate	  neuromuscular	  response	  more	  efficiently.	  	  While	  the	  Bergen	  study	  (2002)	  was	  mainly	  concerned	  with	  the	  physical	  benefits	  of	  aerobic	  exercise,	  a	  series	  of	  case	  studies	  by	  Tabak,	  Aquije,	  and	  Fisher	  (2013)	  investigated	  improvement	  in	  executive	  function.	  One	  participant	  with	  PD	  dementia	  and	  one	  participant	  with	  mild	  cognitive	  impairment	  (MCI)	  completed	  an	  8-­‐week	  program	  of	  aerobic	  exercise	  training	  3-­‐times	  per	  week	  on	  a	  stationary	  bicycle.	  Executive	  function	  evaluation	  pre-­‐	  and	  post-­‐intervention	  included	  the	  Montreal	  Cognitive	  Assessment	  (MoCA),	  the	  Parkinson	  Disease	  Cognitive	  Rating	  Scale	  (PDCRS),	  as	  well	  as	  a	  dual	  task	  involving	  serial	  subtractions	  while	  walking.	  Gait	  speed	  and	  walking	  were	  also	  measured	  with	  the	  10-­‐meter	  walk	  test	  and	  the	  Functional	  Gait	  Assessment,	  respectively.	  	  MoCA	  scores	  for	  both	  participants	  improved	  dramatically	  (17/30	  pre	  to	  24/30	  post,	  and	  22/30	  pre	  to	  27/30	  post),	  and	  PDCRS	  scores	  improved	  (55/134	  pre	  to	  70/134	  post,	  and	  81/143	  pre	  to	  94/143	  post).	  Gait	  speed	  decreased	  for	  one	  participant	  (0.96	  m/s	  to	  0.92	  m/s)	  and	  increased	  for	  the	  other	  (0.73	  m/s	  to	  0.82	  m/s).	  Functional	  gait	  assessment	  scores	  improved	  for	  both	  participants	  (13/30	  to	  23/30,	  and	  25/30	  to	  26/30).	  The	  authors	  also	  noted	  improvements	  in	  quality	  of	  life	  after	  the	  exercise	  intervention.	  Although	  these	  are	  only	  two	  case	  studies,	  it	  is	  interesting	  to	  note	  the	  dramatic	  improvement	  in	  executive	  function.	  	  These	  two	  studies	  investigated	  very	  different	  outcomes	  of	  aerobic	  exercise	  in	  PD.	  Many	  performance	  improvements	  specific	  to	  the	  particular	  tests	  administered	  were	  reported,	  however	  there	  were	  no	  functionally	  relevant	  tasks	  included	  in	  either	  study.	  Aerobic	  exercise	  may	  be	  a	  suitable	  adjunct	  to	  physical	  rehabilitation	  however	  functionally	  relevant	  gains	  in	  movement	  performance	  are	  difficult	  to	  demonstrate	  with	  this	  training	  method.	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2.1.5 Gait Training  
Gait	  disturbances	  are	  common	  in	  PD	  and	  greatly	  increase	  the	  risk	  of	  falling	  which	  results	  in	  a	  loss	  of	  independence	  and	  a	  decrease	  in	  quality	  of	  life.	  Physical	  interventions	  specifically	  designed	  to	  address	  the	  common	  gait	  symptoms	  associated	  with	  PD	  have	  been	  investigated.	  A	  particularly	  popular	  approach	  has	  been	  treadmill	  training.	  	  Herman	  et	  al.	  (2007)	  designed	  a	  six-­‐week	  intensive	  treadmill	  training	  program	  to	  determine	  its	  effect	  on	  gait	  rhythmicity	  and	  functional	  mobility	  in	  PD.	  Nine	  participants	  with	  PD	  were	  assessed	  before,	  immediately	  after,	  and	  4	  to	  5	  weeks	  after	  the	  training	  program.	  Assessment	  included	  the	  motor	  portion	  of	  the	  Unified	  Parkinson	  Disease	  Rating	  Scale	  (UPDRS),	  the	  Short	  Physical	  Performance	  Battery	  (SPPB),	  and	  gait	  analysis	  (walking	  speed,	  average	  stride	  length,	  and	  stride-­‐to-­‐stride	  variability	  via	  pressure-­‐sensitive	  insoles).	  The	  training	  involved	  four	  30-­‐minute	  sessions	  per	  week,	  with	  the	  treadmill	  speed	  progressively	  increasing	  each	  week	  according	  to	  each	  participant’s	  speed.	  	  UPDRS	  and	  SPPB	  scores	  significantly	  improved,	  while	  gait	  speed	  and	  stride	  length	  significantly	  increased.	  UPDRS,	  SPPB	  scores,	  gait	  speed	  and	  stride	  length	  remained	  significantly	  improved	  at	  the	  4	  to	  5	  weeks	  post-­‐training	  testing	  compared	  to	  baseline	  values.	  	  Another	  study	  by	  Protas	  and	  colleagues	  (2005)	  implemented	  an	  eight-­‐week	  treadmill	  gait	  and	  step	  training	  program	  involving	  3	  one-­‐hour	  sessions	  per	  week.	  Gait	  training	  consisted	  of	  walking	  on	  a	  treadmill	  at	  a	  speed	  greater	  than	  over	  ground	  walking	  speed	  while	  walking	  in	  4	  directions	  and	  while	  supported	  in	  a	  harness	  for	  safety.	  Step	  training	  consisted	  of	  suddenly	  turning	  the	  treadmill	  on	  and	  off	  while	  the	  subject	  stood	  in	  the	  safety	  harness	  facing	  either	  forwards,	  backwards,	  or	  sideways.	  Nine	  participants	  with	  PD	  completed	  the	  training	  protocol	  and	  another	  nine	  participants	  with	  PD	  did	  not.	  Pre-­‐	  and	  post-­‐testing	  included	  and	  evaluation	  of	  gait	  parameters	  using	  an	  instrumented	  walkway,	  recording	  of	  time	  required	  to	  step	  onto	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and	  back	  down	  from	  an	  8.8	  cm	  step	  for	  5	  consecutive	  steps,	  and	  report	  of	  falls	  in	  the	  two	  weeks	  prior	  to	  and	  two	  weeks	  after	  gait	  training.	  	  The	  training	  group	  demonstrated	  significant	  improvements	  in	  gait	  speed	  while	  the	  non-­‐training	  group	  did	  not.	  Furthermore,	  the	  training	  group	  reported	  significantly	  less	  falls	  after	  gait	  training	  while	  the	  non-­‐training	  group	  did	  not	  change.	  	  Although	  these	  studies	  show	  promising	  results	  that	  treadmill	  training	  may	  improve	  gait	  parameters	  and	  mobility,	  these	  improvements	  were	  limited	  to	  walking	  in	  a	  straight	  line,	  without	  the	  features	  of	  everyday	  environments	  typically	  encountered	  by	  community-­‐dwelling	  adults.	  These	  would	  include	  tripping	  hazards,	  sudden	  changes	  in	  direction,	  attentional	  distractors,	  among	  others.	  Gait	  rehabilitation	  should	  be	  done	  via	  realistic	  tasks	  that	  incorporate	  the	  unpredictable	  features	  of	  the	  “real-­‐world”.	  	  
2.2 Rehabilitation with Virtual Systems 
The	  flexibility	  and	  level	  of	  control	  offered	  by	  virtual	  systems	  has	  made	  it	  an	  attractive	  option	  for	  delivering	  rehabilitation	  programming	  to	  people	  with	  PD.	  However	  it	  is	  still	  in	  the	  early	  stages	  of	  investigation	  as	  a	  true	  rehabilitation	  tool.	  Some	  gaming	  technology,	  such	  as	  the	  Wii,	  has	  been	  investigated	  for	  rehabilitative	  purposes,	  while	  other	  studies	  have	  implemented	  custom	  programming	  and	  hardware.	  	  
2.2.1 Nintendo Wii™ 
A	  series	  of	  two	  studies	  by	  the	  same	  group	  (Pompeu,	  dos	  Santos	  Mendes,	  da	  Silva,	  Lobo,	  de	  Paula	  Oliveira,	  Zomignani,	  et	  al.,	  2012;	  dos	  Santo	  Mendes,	  Pompeu,	  Lobo,	  da	  Silva,	  de	  Paula	  Oliveira,	  Zomignani,	  et	  al.,	  2012)	  investigated	  using	  the	  Nintendo	  WiiTM	  for	  cognitive	  motor	  training.	  The	  first	  study	  by	  this	  group	  (Pompeu	  et	  al.,	  2012)	  investigated	  the	  effect	  of	  Wii-­‐based	  training	  on	  activities	  of	  daily	  living.	  The	  Wii	  Fit	  program	  was	  implemented	  with	  the	  rationale	  that	  these	  games	  might	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promote	  balance	  training,	  and	  cognitive-­‐motor	  integration	  practice.	  All	  32	  participants	  completed	  14	  one-­‐hour	  sessions	  twice	  per	  week	  over	  seven	  weeks.	  	  The	  first	  thirty	  minutes	  consisted	  of	  global	  exercises	  (stretching,	  strengthening,	  axial	  mobility),	  the	  control	  group	  (n	  =	  16)	  then	  completed	  balance	  exercise	  therapy	  and	  the	  Wii	  Fit	  group	  (n	  =	  16)	  completed	  10	  Wii	  Fit	  games,	  specially	  selected	  for	  incorporating	  motor	  and	  cognitive	  tasks.	  	  The	  Wii	  Fit	  group	  demonstrated	  improvement	  in	  performance	  of	  the	  games	  over	  the	  seven-­‐week	  training	  period,	  demonstrating	  their	  ability	  to	  learn.	  Both	  the	  control	  and	  Wii	  Fit	  groups	  demonstrated	  a	  significant	  improvement	  in	  the	  UPDRS	  section	  II	  (activities	  of	  daily	  living)	  and	  Berg	  balance	  scores.	  This	  improvement	  in	  scores	  remained	  for	  sixty	  days	  after	  training.	  There	  was	  no	  apparent	  benefit	  of	  the	  Wii	  Fit	  program	  over	  conventional	  balance	  training,	  however	  the	  virtual	  program	  was	  just	  as	  effective.	  The	  authors	  also	  suggested	  a	  cognitive	  improvement	  induced	  by	  the	  increase	  in	  physical	  activity	  achieved	  by	  the	  balance	  training.	  	  The	  second	  study	  (dos	  Santos	  Mendes	  et	  al.,	  2012)	  involved	  a	  similar	  Wii	  Fit	  training	  protocol,	  however	  specifically	  addressed	  learning,	  retention	  and	  transfer	  of	  performance	  of	  participants	  with	  PD	  (n	  =	  16)	  compared	  to	  healthy	  controls	  (n	  =	  11).	  The	  training	  program	  consisted	  of	  twice-­‐weekly	  training	  sessions	  over	  fourteen	  weeks.	  Each	  session	  included	  global	  mobility	  exercises	  as	  well	  as	  training	  on	  ten	  Wii	  Fit	  games.	  Performance	  of	  the	  games	  was	  scored	  after	  each	  week	  to	  monitor	  performance	  improvement	  and	  again	  at	  60	  days	  post-­‐training	  to	  determine	  retention.	  The	  functional	  reach	  test	  was	  the	  main	  outcome	  measure	  to	  demonstrate	  transfer	  effects	  and	  was	  performed	  at	  baseline,	  one	  week	  after	  training	  and	  sixty	  days	  after	  training.	  	  Not	  surprisingly,	  the	  authors	  concluded	  that,	  overall,	  the	  PD	  group	  demonstrated	  reduced	  learning	  and	  retention	  compared	  to	  the	  healthy	  control	  group	  for	  the	  Wii	  Fit	  games.	  For	  the	  transfer	  of	  learning	  effects	  to	  the	  functional	  reach	  test,	  both	  the	  one-­‐week	  and	  sixty-­‐day	  post-­‐training	  assessments	  were	  significantly	  improved	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compared	  to	  baseline	  values	  which	  suggests	  the	  PD	  group	  was	  able	  to	  transfer	  a	  motor	  ability	  from	  the	  Wii	  training	  to	  an	  untrained	  task.	  	  Although	  both	  of	  these	  Wii	  studies	  demonstrated	  some	  performance	  improvement,	  there	  are	  limitations	  inherent	  to	  Wii	  programming	  that	  make	  it	  difficult	  to	  apply	  to	  a	  task-­‐specific	  rehabilitation	  program.	  Both	  of	  these	  protocols	  were	  limited	  to	  a	  defined	  set	  of	  Wii	  Fit	  games	  that	  may	  not	  directly	  apply	  to	  realistic	  everyday	  settings	  or	  ADLs.	  Additionally,	  the	  games	  are	  not	  scalable,	  or	  modifiable,	  to	  each	  individual’s	  needs	  or	  progress.	  	  
2.2.2 Virtual Reality  
There	  have	  been	  two	  recent	  studies	  that	  incorporate	  virtual	  reality	  technologies	  in	  a	  rehabilitative	  setting	  to	  directly	  address	  some	  of	  the	  most	  debilitating	  symptoms	  in	  PD.	  	  The	  first	  study	  by	  Mirelman	  and	  colleagues	  (2011)	  incorporated	  virtual	  obstacles	  with	  treadmill	  training.	  Twenty	  participants	  with	  PD	  completed	  18	  sessions	  over	  six	  weeks	  of	  progressive	  and	  intensive	  treadmill	  training.	  Outcome	  measures	  included	  gait	  speed	  with	  and	  without	  a	  dual	  task,	  and	  while	  navigating	  around	  obstacles.	  These	  measures	  were	  tested	  at	  baseline,	  upon	  completion	  of	  training,	  and	  4	  weeks	  post-­‐training	  to	  determine	  retention	  effects.	  	  Participants	  were	  required	  to	  walk	  on	  a	  treadmill	  while	  viewing	  a	  virtual	  environment	  simulated	  on	  a	  screen	  presented	  in	  front	  of	  them.	  The	  virtual	  system	  simulated	  an	  outdoor	  environment	  with	  obstacles	  of	  varying	  size	  and	  frequency	  that	  were	  to	  be	  avoided.	  The	  virtual	  environment	  was	  specifically	  designed	  for	  this	  protocol	  and	  imposed	  an	  attentional	  cognitive	  load	  as	  well	  as	  processing	  of	  visual	  stimuli	  while	  participants	  were	  walking.	  With	  every	  level	  that	  was	  cleared,	  the	  difficulty	  of	  the	  virtual	  environment	  (i.e.,	  frequency,	  size	  of	  obstacles)	  was	  increased.	  	  After	  training,	  gait	  speed,	  stride	  length,	  and	  stride	  time	  had	  significantly	  increased	  and	  remained	  elevated	  at	  the	  four-­‐week	  follow-­‐up	  session,	  both	  with	  and	  without	  a	  
19 
 
dual-­‐task.	  Gait	  speed	  while	  navigating	  obstacles	  also	  improved	  after	  training	  and	  was	  again	  maintained	  at	  the	  follow-­‐up	  assessment.	  It	  appears	  that	  this	  training	  program	  had	  a	  beneficial	  impact	  on	  the	  participant’s	  walking	  ability	  and	  gait	  patterns.	  	  However,	  this	  protocol	  confines	  participants	  to	  straight-­‐walking,	  a	  gait	  pattern	  that	  is	  relatively	  uncommon	  in	  “real-­‐life”	  environments.	  Furthermore	  the	  virtual	  system	  was	  not	  portable	  and	  the	  environment	  was	  not	  immersive	  which	  again	  limits	  the	  implementation	  of	  more	  realistic	  ADLs.	  	  A	  randomized	  controlled	  trial	  by	  Yen	  and	  colleagues	  (2011)	  aimed	  to	  determine	  the	  effects	  of	  VR-­‐augmented	  balance	  training	  on	  postural	  control	  and	  how	  this	  compares	  to	  conventional	  balance	  (CB)	  training	  as	  well	  as	  an	  untrained	  control	  group	  (n	  =	  12	  in	  each	  group).	  Posturography	  tests	  with	  single-­‐	  and	  dual-­‐task	  conditions	  were	  performed	  at	  baseline,	  after	  training,	  and	  after	  a	  follow-­‐up	  period	  of	  four	  weeks.	  The	  VR	  and	  CB	  groups	  received	  balance	  training	  for	  six	  weeks.	  The	  VR	  training	  hardware	  included	  a	  dynamic	  “balance	  board”,	  an	  LCD	  screen,	  and	  a	  personal	  computer.	  Two	  games	  were	  simulated	  to	  allow	  participants	  to	  practice	  weight	  shifting	  in	  different	  directions.	  Both	  indoor	  and	  outdoor	  environments	  were	  simulated.	  The	  CB	  training	  program	  consisted	  of	  exercises	  involving	  static	  stance,	  dynamic	  weight	  shifting,	  and	  external	  perturbations.	  	  After	  training,	  both	  the	  VR	  and	  CB	  groups	  had	  significantly	  improved	  stance	  stability,	  while	  the	  control	  group	  experienced	  no	  change.	  The	  authors	  explained	  that	  the	  training	  groups	  were	  able	  to	  more	  effectively	  use	  sensory	  information	  for	  postural	  control	  compared	  to	  the	  control	  group	  after	  training.	  However,	  there	  was	  no	  difference	  between	  the	  VR	  and	  CB	  groups	  with	  respect	  to	  reducing	  attentional	  demand	  for	  postural	  stability.	  This	  virtual	  system	  allowed	  for	  more	  interaction	  between	  a	  “real-­‐world”	  object	  (i.e.,	  the	  dynamic	  balance	  board)	  while	  viewing	  a	  virtual	  scene.	  However	  the	  virtual	  scene	  was	  delivered	  only	  via	  an	  LCD	  screen,	  and	  may	  not	  have	  been	  immersive	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enough	  to	  simulate	  realistic	  environments.	  Additionally,	  by	  confining	  the	  participants	  to	  one	  position	  on	  the	  balance	  board,	  they	  are	  prevented	  from	  practicing	  realistic	  ADLs.	  This	  raises	  questions	  as	  to	  the	  utility	  of	  practicing	  static	  balance	  and	  postural	  control	  if	  it	  may	  not	  be	  directly	  applicable	  in	  everyday	  life.	  	  
2.2.3 Virtual Reality for Cognitive Training 
A	  study	  by	  Sinforiani	  and	  colleagues	  (2004)	  included	  twenty	  PD	  participants	  with	  mild	  cognitive	  impairment	  (MMSE	  score	  25.1	  ±	  2.5)	  who	  underwent	  twelve	  one-­‐hour	  sessions	  of	  “cognitive	  rehabilitation”	  over	  six	  weeks.	  The	  cognitive	  training	  program	  consisted	  of	  an	  Italian	  computer	  program	  (Tonetta,	  1995)	  designed	  to	  stimulate	  attention,	  abstract	  reasoning,	  and	  visuo-­‐spatial	  abilities	  at	  different	  levels	  of	  complexity.	  Neuropsychological	  tests	  were	  administered	  pre-­‐	  and	  post-­‐training	  as	  well	  as	  a	  six	  month	  follow-­‐up	  to	  determine	  lasting	  effects	  of	  the	  training.	  Participants	  had	  significantly	  improved	  performance	  on	  Babcock’s	  story,	  phonological	  word	  fluency,	  and	  Raven’s	  matrices.	  Performance	  at	  the	  six-­‐month	  follow-­‐up	  was	  not	  significantly	  different	  than	  the	  post-­‐testing	  scores.	  The	  authors	  suggested	  that	  the	  improvement	  in	  performance	  was	  a	  result	  of	  reinforced	  cognitive	  strategies,	  particularly	  enhanced	  frontal	  function,	  which	  is	  impaired	  in	  PD.	  The	  practical	  benefit	  of	  cognitive	  training	  alone	  may	  be	  limited.	  However	  the	  study	  by	  Sinforiani	  and	  colleagues	  demonstrates	  that	  cognitive	  ability	  in	  PD	  may	  be	  improved	  with	  practice.	  Therefore	  people	  living	  with	  PD	  are	  ideal	  candidates	  for	  a	  rehabilitative	  program	  that	  includes	  a	  cognitive	  training	  component	  as	  well.	  	  
2.3 Limitations of Current Rehabilitation Approaches 
Rehabilitation	  techniques	  are	  an	  important	  option	  to	  help	  maintain	  mobility	  in	  addition	  to	  pharmacological	  treatment.	  Rehabilitation	  training	  is	  predominantly	  catered	  to	  recoverable	  symptoms	  (e.g.	  gait	  parameters,	  balance	  control)	  via	  gait	  training,	  cueing,	  or	  with	  the	  addition	  of	  assistive	  devices.	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Physical	  therapy	  practices	  are	  rigid	  in	  that	  they	  are	  not	  specifically	  applicable	  to	  the	  PD	  population.	  Typical	  approaches	  do	  not	  address	  how	  constraints	  on	  mobility	  specific	  to	  PD	  such	  as	  rigidity,	  bradykinesia,	  freezing,	  poor	  sensory	  integration,	  inflexible	  motor	  program	  selection,	  and	  impaired	  cognitive	  processing,	  can	  limit	  mobility.	  There	  have	  been	  some	  efforts	  to	  identify	  these	  shortcomings	  of	  typical	  physical	  therapy	  practice	  and	  to	  implement	  exercise	  training	  specific	  to	  PD	  (King	  &	  Horak,	  2009).	  However,	  even	  these	  programs	  are	  rigid	  and	  do	  not	  include	  an	  easily	  scalable	  program	  that	  would	  be	  effective	  for	  all	  stages	  of	  disease.	  There	  have	  been	  some	  loose	  guidelines	  presented	  for	  physical	  therapy	  outcomes	  (Keus,	  Munneke,	  Nijkrakem	  Kwakkel,	  &	  Bloehm,	  2009).	  However	  they	  are	  not	  founded	  in	  functionally	  relevant	  tasks	  or	  skills	  that	  would	  be	  directly	  applicable	  to	  activities	  of	  daily	  living.	  Furthermore,	  physical	  therapy	  does	  not	  address	  the	  motor-­‐cognitive	  issues	  in	  PD,	  as	  it	  is	  more	  focused	  on	  the	  motor	  symptoms	  of	  disease.	  	  Occupational	  therapy	  is	  oriented	  to	  more	  task-­‐driven	  and	  context-­‐dependent	  strategies	  (i.e.	  cueing	  and	  assistive	  devices	  to	  aid	  in	  frequently	  encountered	  environments).	  However,	  there	  is	  often	  little	  flexibility	  for	  individualized	  programming	  in	  this	  field.	  Every	  patient	  has	  unique	  environments	  they	  encounter	  on	  a	  daily	  basis,	  for	  example	  their	  particular	  pharmacy,	  grocery	  store,	  street	  crossing	  or	  home.	  It	  is	  impossible	  to	  cater	  one	  physical	  space	  or	  a	  particular	  treatment	  regimen	  to	  every	  patient.	  Services	  do	  exist	  for	  occupational	  therapists	  to	  go	  to	  the	  patient’s	  home,	  however	  these	  are	  financially	  unfeasible	  for	  many	  families.	  As	  a	  result,	  people	  with	  PD	  are	  limited	  to	  the	  standardized	  rehabilitation	  programs,	  often	  in	  fixed	  locations,	  to	  learn	  isolated	  strategies	  that	  may	  or	  may	  not	  be	  incorporable	  into	  their	  everyday	  “real”	  life.	  	  
2.4 Rationale for Present Study  
People living with Parkinson disease are ideal candidates for rehabilitation. Many of the 
classical symptoms associated with PD are prime targets for rehabilitation programs.   
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While people living with PD clearly have a physical impairment, by implementing 
specific techniques such as those described in this chapter, performance can be improved 
from baseline. This may suggest that the overall motor system is not destroyed and there 
is room for improvement in daily functioning.  
People living with PD commonly have cognitive impairments. This requires an 
integrative approach to rehabilitation including both motor and cognitive exercise within 
a single treatment program. It is also important to know that participants with PD who 
have cognitive impairments have been shown to benefit from cognitive training and are 
thus amenable to rehabilitation (Sinforiani, et al., 2004). 
There is literature to show that exercise is a reliable factor for predicting quality of life in 
people living with PD. Falling and fear of falling are highly correlated with quality of life 
(Brozova, Stochl, Roth, & Ruzicka, 2009). If new strategies can be learned within a 
physical rehabilitation program that may be applied to everyday life tasks, there is 
potential to increase confidence of completing activities without falling.  
The symptoms of PD outlined in the introductory chapter described various motor 
disabilities, cognitive impairments, and decreased quality of life. There is sufficient 
evidence that each of these areas may be improved with increased exercise and by 
learning new motor strategies that may be applied to everyday life. For these reasons, the 
PD population is an ideal “test subject” for obtaining benefit from any rehabilitative 
program.  
2.4.1 Criteria for Successful Rehabilitation in PD 
In	  order	  to	  implement	  a	  successful	  rehabilitation	  program	  for	  people	  living	  with	  PD,	  it	  must	  be	  designed	  with	  the	  ability	  to	  address	  the	  major	  areas	  of	  concern	  simultaneously.	  A	  rehabilitation	  technique	  must	  be	  designed	  that	  allows	  context-­‐dependent	  functional	  training	  of	  everyday	  tasks	  that	  strongly	  considers	  the	  typical	  cognitive	  deficits	  in	  PD.	  There	  is	  a	  strong	  interaction	  between	  the	  cognitive	  and	  motor	  systems	  that	  together	  create	  the	  unique	  symptoms	  encountered	  by	  people	  living	  with	  PD	  in	  everyday	  tasks.	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By	  implementing	  these	  types	  of	  programs	  in	  the	  community,	  participants	  may	  be	  exposed	  to	  a	  social	  and	  supportive	  setting	  while	  learning	  strategies	  to	  improve	  movement	  ability	  and	  therefore	  increase	  mobility.	  As	  described	  above,	  these	  skills	  would	  also	  contribute	  to	  overall	  quality	  of	  life.	  	  
 
2.4.2 Augmented Reality for Rehabilitation in PD 
Immersive augmented reality (IAR) is a type of virtual reality and may be an optimal tool 
for meeting these rehabilitative criteria for people living with PD. This type of platform 
would provide a flexible and scalable means of implementing realistic, functionally 
relevant tasks. Most importantly, by making use of virtual features, the major areas of 
concern (motor, cognitive, quality of life) in the PD population may be addressed 
simultaneously. 
IAR technology is able to simulate realistically hazardous environments that are 
expensive to physically recreate for training purposes within a rehabilitative context. 
There have been several types of programs created to simulate fully immersive virtual 
environments for video games and military training that include highly sophisticated and 
expensive equipment. The goal of the current rehabilitation program was to design a 
functional system that provides some level of immersion (i.e. a sense of “being there”), is 
interactive, user-friendly, and most of all affordable, so it may be implemented in the 
community within a manageable cost.  
Other groups have attempted to implement virtual systems in the PD population with the 
same objective. Studies have focused on aspects of reaching, problem–solving and 
navigation using non– ambulatory, desktop–based systems (Albani, Pignatti, Bertella, 
Priano, Semenza, Molinari et al., 2002;  Messier, Adamovich, Jack, Hening, Sage & 
Poizner, 2007). Mirelman et al. (2011) used immersive virtual environments to provide 
visual context and cognitive/motor challenges in a VR gait–training program. However, 
the trajectory of ambulation was restricted to treadmill walking (Mirelman, Maidan, 
Herman, Deutsch, Giladi, & Hausdorff, 2011). The limitations to using a treadmill or 
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desktop system are obvious; participants must be able to ambulate and practice 
movement strategies in realistic situations in order to have some transferability to 
activities of daily living.  
The system must also be wireless to allow full ambulation in an open space, to ensure the 
user is not confined to a desktop or a treadmill, but is able to ambulate freely along an 
unspecified path and in any direction.  
A final area of concern would be the level of presence created by the program. 
Immersiveness contributes to presence and is a physical feature of the VR system, 
defined by the amount of display, to all sensory modalities, that is delivered to the user. 
Presence is defined as the sense of being there in the virtual environment, signaled by 
people acting and responding realistically to virtual situations and events (Slater et al., 
2009). Presence may be thought of as a subjective reaction to the system. It is imperative 
that a system appears to be realistic to the user if any rehabilitative benefit is to be 
achieved from the program. A fundamental requirement within a virtual reality system is 
the maintenance of the sensorimotor loop: the continued, predictable correlation between 
proprioception of motoric movements and sensory data and the motoric output by the 
user. A head-turn must result in a concomitant and predictable change in the visual field; 
a movement of the body must result in the expected correlated sensory and sensed 
physical changes that have been learned over a lifetime (Slater et al, 2009). 
People living with PD have sensory processing and integration deficits. For this reason, it 
is important to understand how users with PD perceive the artificial sensory information 
and how this may be different than controls’ perception. The reported level of presence 
experienced by the user is necessary information to determine if the system is able to 
simulate realistic scenarios, and therefore amenable to rehabilitative tasks and goals for 
PD. 
In summary, there are three areas to be addressed in relation to the use of VR systems in 
physical rehabilitation for people living with PD: 1) the effect of the virtual environment 
may result in differences in motor task performance compared to “real world” situations; 
2) it is unknown whether performance may improve across visits; and 3) if this change in 
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performance over time might be different for people with PD compared to controls. This 
information would also provide insight about a period of accommodation that may occur 
when participants are introduced to the IAR system. 
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Chapter 3  
3 Method 
The experimental protocol was approved by the Health Sciences Research Ethics Board 
at Western University. The method will be described in several sections: participants, 
system development, tasks in the immersive augmented reality (IAR) environment, and 
presence questionnaire.  
3.1 Participants 
Participants with PD were recruited from a movement disorders clinic at the London 
Health Sciences Centre in London, Ontario. Healthy controls were recruited from the 
community or were spouses of the participants with PD. Inclusion and exclusion criteria 
are in Appendix A.  In	  order	  to	  describe	  the	  PD	  sample	  included	  in	  this	  thesis	  in	  the	  context	  of	  being	  ideal	  for	  rehabilitation,	  several	  measures	  were	  collected.	  Each	  scale	  was	  included	  to	  specifically	  measure	  and	  describe	  the	  presence	  of	  a	  particular	  symptom	  or	  deficit	  in	  the	  sample.	  
To describe motor impairments, a motor profile was generated for each PD participant. 
The motor profile consisted of several scores that, when considered together, were able to 
provide a well-rounded description of the disease and motor status both for each 
participant individually and for the PD group as a whole. The disease duration was 
obtained from the onset of the earliest clinical sign in the patient chart and was recorded 
in years. The Hoehn & Yahr stage was extracted from the most recent clinic note (within 
a maximum of six months of the study date). The Hoehn and Yahr staging system ranges 
from 1-5 and is commonly used for describing the progression of disease for a particular 
patient. The Levodopa equivalent dose (LED) was also calculated according to 
Tomlinson et. al (2010) as a further proxy for disease severity. A select number of items 
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from the Unified Parkinson Disease Rating Scale were also scored to add to the 
participant motor profiles.  
Participants completed a number of scales. More complete descriptions and copies of 
each scale are in appendices B to F.  The University of Toronto’s Community Balance 
and Mobility (CB&M) test was administered to all participants. The CB&M was 
designed to evaluate balance and mobility through relatively difficult and dynamic tasks 
in patients who, although ambulatory, have balance impairments which reduce their full 
engagement in community living (Howe, et. al, 2006). There is a maximum score of 96 
for the CB&M. Age of all participants in years was also collected.  
A cognitive screening test, the Montreal Cognitive Assessment (MoCA) was 
administered to measure cognitive ability. The MoCA assesses different cognitive 
domains: attention and concentration, executive functions, memory, language, 
visuoconstructional skills, conceptual thinking, calculations, and orientation. There is a 
maximum possible score of 30 and a score of 26 or higher is considered normal. A 
shortened version of the Parkinson Disease Questionnaire, the PDQ-8, is considered to be 
a reliable, valid, responsive, acceptable and feasible as the tool for assessment of quality 
of life in PD patients. The PDQ-8 score is a percentage of 32 points scored across the 
eight items. The Activities-specific Balance Confidence (ABC) scale is a sixteen-item 
scale frequently used for assessing balance confidence in the elderly while performing 
functional activities. Balance confidence and fear of falling is highly correlated with 
QOL (Adkin, Frank, & Jog, 2003). The ABC score is calculated as an average percentage 
for all items. 
Scales that were administered to both groups were analyzed using an independent T-test. 
3.2 Immersive Augmented Reality System Development  
The IAR system was developed in three stages: construction of the physical space in 
which the virtual environments would be implemented, assembly of the necessary 
hardware components for simulating the environment to the user, and design of the 
software to configure the environments.  
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3.2.1 Physical Space 
All IAR scenes were applied within the same physical space: an empty room of 
dimensions 6.68 m × 4.92 m. The room was lined with heavy white vinyl curtains to 
which 110 fiducial markers were installed. Fiducial markers are points of reference that a 
computer vision system uses to measure the position of the camera with respect to each 
marker, (i.e., they provide information to the system as to where the user is standing and 
therefore what image should be projected to the user). An image of the room with the 
markers installed is in appendix G.  
3.2.2 Hardware 
The hardware consisted of three components: a head-mounted display (HMD), a camera 
system, and a laptop. The Vuzix iWear® 920VR™ visor (Vuzix Corporation: Rochester, 
New York) was the HMD used for this system and projected the IAR environments to the 
user. It was mounted with the Vuzix iWear® CamAR™ (Vuzix Corporation: Rochester, 
New York) to capture information from the fiducial markers about the users position. The 
visor was connected to a light-weight laptop, the ASUS® UX31 (ASUSTeK Computer 
Inc., Taipei, Taiwan) weighing 3.08 lbs, stored in a small backpack worn by the 
participant. The camera fixed to the visor transmitted the information from the fiducial 
markers to the IAR software (running in the backpack), which in turn projected the 
simulated scene back to the visor to be viewed by the participant. Images of all 
equipment are in appendix H. There were some real-world objects that were specifically 
coded into the software to allow the participants to interact with solid objects while 
experiencing the IAR environments. Some examples are cereal boxes, a watering can, 
and grocery bins. These were included in order to simulate natural interactions between 
the users and the objects while immersed in a virtual environment. 
3.2.3 Software 
The IAR scenes were designed using Open Graphics Library (OpenGL) (Silicon 
Graphics, 2012), an open access software program. Three scenes were developed to pilot 
the design of functionally relevant scenes. A scene was created of three locations 
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commonly encountered by community-dwelling adults: a living room scene inside a 
home, a grocery store scene in the community, and a street crossing scene in an outdoor 
environment.  The house in which the living room scene was situated as well as the 
outdoor setting of the street crossing were completely artificial in their rendering. 
However, the grocery store scene was uniquely rendered by integrating digital images of 
a real grocery store into the program. Images of each scene are in Appendix I. For 
specific programming procedure, please refer to Ayala Garcia (2012). 
After participants completed the IAR protocol (described below), they were asked to 
complete a presence questionnaire (Witmer & Singer, 1999; Appendix J). The presence 
questionnaire was designed to evaluate presence in virtual environments. The 
questionnaire consists of 33 questions rated from 1 to 7 on a Likert scale. The scores 
from each question are summed to obtain the participant’s score with a maximum score 
of 231 points with a higher score implying a higher perceived presence. The full presence 
questionnaire as well as a description of the reliability and validity of this measure is in 
Appendix J.   
3.3 Immersive Augmented Reality and Real World Protocol 
The protocol consisted of three weekly visits to the testing centre. At the first visit, 
several baseline assessments were conducted (described above). A task specifically 
designed for each of the three scenes was performed in the IAR environment followed by 
an analogous task in the same physical space, but in the real-world (RW) (i.e., without 
the visor). In the IAR environment, the patient saw the entire scene rendered, while in the 
RW environment, the patient saw the whole room as is without any scene rendering.  
In the living room scene, participants were required to stand still in front of a long table 
with two rows of potted flowers. Participants were handed a watering can (visible 
through the visor) and asked to reach forward to “water” the plant furthest away from 
them on the left and then on the right. Three trials were completed in each direction. This 
was analogous to the Reach Test (Newton, 2001) that was performed in the RW. The 
maximum anterior limit of the arm was recorded as the dependent variable for this task.  
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In the cereal aisle of the grocery store, participants had to put cereal boxes into five 
baskets placed on the ground throughout the room and numbered 1 through 5. 
Participants were given a random number sequence of the numbers 1 to 5 to remember. 
This sequence represented the order the cereal boxes were to be filled. Three trials of this 
task were completed, followed by three tasks in the RW. The dependent variables were 
time to complete the trial and accuracy of the baskets filled.   
Finally at the street crossing scene, participants were asked to walk a specified distance at 
a “regular, comfortable pace”. This was completed in the IAR environment as a street 
crossing task and in the RW as a simple walking task. The street sign always displayed 
the “white man” walking symbol. The dependent variable was the time in seconds 
required to walk the specified distance. The IAR and RW task were completed at each 
weekly visit.  
Data Analysis 
Multivariate analysis of variance (MANOVA) models were used for each task. Group 
(PD or control), environment (IAR or RW), and week (1, 2, or 3) were independent 
variables and included all dependent variables listed above.  
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Chapter 4  
4 Results 
A	  low-­‐cost,	  fully	  ambulatory	  IAR	  system	  was	  implemented	  in	  both	  a	  PD	  and	  control	  group	  of	  older	  adults.	  Three	  virtual	  scenes	  were	  designed	  and	  implemented.	  Results	  will	  be	  presented	  with	  respect	  to	  the	  participant	  data,	  tolerability	  of	  the	  system,	  the	  IAR	  protocol,	  and	  finally	  the	  presence	  questionnaire.	  	  
4.1 Participants 
Twenty-two people with PD (15 male, mean age = 67.1 ± 6.1 years, mean disease 
duration = 6.2 ± 3.3 years) and 11 controls (6 male, mean age = 64.1 ± 5.6 years) 
completed the scales protocol.  
The average disease duration for the PD group was 6.18 years (SD ± 3.30 years). The 
average Hoehn & Yahr Stage for the PD group was 2.36 ± 0.49. The mean levodopa 
equivalent dose was 401.4 ± 276.3 mg/day. Disease duration, Hoehn & Yahr score, and 
LED data were not collected in the control group, and are therefore presented as means 
with standard deviation values for the PD group only. The control group scored 
significantly higher on the CB&M than the PD group (Control mean = 72.18 ± 14.82, PD 
mean = 57.73 ± 16.62, p = 0.02). Motor profiles of the participants with PD are in Table 
1, and scores for select UPDRS items are listed in Table 4.1. 
Table 4.1 Motor profiles of participants with PD. 
Participant 
Disease 
Duration*  
PDQ-
8** 
CBM¥ 
 
H&Y 
stage 
LED€ 
VR-01 2 3.125 61 2 400 
VR-02 8 3.125 59 2 700 
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VR-03 7 12.5 76 2 600 
VR-04 4 31.25 27 2 600 
VR-05 5 12.5 65 2 0 
VR-06 2 21.875 64 3 400 
VR-07 4 31.25 19 3 100 
VR-08 11 18.75 71 2 1250 
VR-09 5 21.875 71 2 300 
VR-10 5 6.25 57 2 300 
VR-11 10 18.75 47 3 400 
VR-12 2 21.875 45 2 600 
VR-13 10 15.625 45 3 0 
VR-14 10 9.375 35 2 400 
VR-15 10 18.75 47 3 600 
VR-16 6 17.1875 75 2 380 
VR-17 1 28.125 51 2 0 
VR-18 9 28.125 64 2 300 
VR-19 10 18.75 67 3 400 
VR-20 3 31.25 74 3 300 
VR-21 9 6.25 84 2 500 
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VR-22 3 6.25 66 3 300 
Mean 6.18 17.4 57.7 2.36 401.4 
SD 3.30 9.18 16.6 0.49 276.3 
*Disease duration is number of years from onset of symptoms (not diagnosis). 
**Parkinson Disease Questionnaire-8 (PDQ-8) is a percentage of the maximum score of 
32 points for the 8 items. 
¥Community Balance and Mobility (CBM) is scored out of 96. 
€LED is levodopa equivalent dose in mg per day. 
________________________________________________________________________ 
Table 4.2. Select UPDRS item scores 
Participant  #18 #20 #22 #23 #24 #25 #26 #29 #30 Total 
VR-01 0 0 1 0 0 0 0 0 0 1 
VR-02 0 2 4 2 1 2 0 0 0 11 
VR-03 1 1 2 0 0 1 0 0 0 5 
VR-04 - 4 - - - - - - - - 
VR-05 1 5 0 2 0 0 2 1 0 11 
VR-06 1 0 7 3 2 2 0 2 2 19 
VR-07 0 4 1 2 2 2 2 1 1 15 
VR-08 1 4 4 3 3 1 1 1 2 20 
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VR-09 0 0 2 4 0 0 0 0 0 6 
VR-10 1 1 2.5 2 0 0 2 1 1 10.5 
VR-11 1 3.5 3 4 2 0 0 0 0 13.5 
VR-12 0 2 4 3 1 4.5 0 0 0 14.5 
VR-13 0 2.5 5 3 3 0 1 0 0 14.5 
VR-14 0 6 2 2 0 2 1 1 0 14 
VR-15 1 2 4 2 2 2 2 0 0 15 
VR-16 0 0 4 0 0 0 0 0 0 4 
VR-17 0 3 2 0 0 1 0 1 0 7 
VR-18 1 0 9 4 2 2 0 0 1 19 
VR-19 0 0 2 2 1 1 0 0 0 6 
VR-20 0 2 9 1 2 2 0 1 0 17 
VR-21 1 0 5 3 2 4 0 0 0 15 
VR-22 0 8 0 2 1 0 0 1 1 3 
Mean          11.5 
SD          5.67 
________________________________________________________________________  
The mean score on the MoCA for the control group was 26.0 ± 2.37 and 25.2 ± 4.02 for 
the PD group. These scores were not significantly different.  
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The average score of the PDQ-8 was 17.4 ± 9.18 out of a maximum of 100%. The mean 
score on the ABC for the control group was 92.4 ± 8.23 and for the PD group was 83.8 ± 
11.0 out of a maximum score of 100%. A comparison of scores for all scales is in Table 
4.3.  
Table 4.3. Scores of demographic scales for the PD and control groups. 
Measure PD (Mean±SD) Control (Mean±SD) 
Age (years) 67.1 ± 6.10 64.1 ± 5.61 
Activities Balance Confidence  83.8 ± 11.0* 92.4 ± 8.23* 
Montreal Cognitive Assessment 25.2 ± 4.02 26.0 ± 2.37 
Community Balance & Mobility  57.7 ± 16.6* 72.2 ± 14.8* 
*p < 0.05 
________________________________________________________________________ 
4.2 Tolerability of the System  
The system was well tolerated by both the PD and control groups, with no reports of 
disorientation or nausea. All participants were able to complete the full protocol other 
than two who wore either bi-or tri-focal prescription lenses. These participants had 
orientation issues in one scene only and experienced vertical tracking issues as the scene 
was projected through the various prescriptions of the lenses. Minor complaints with the 
comfort of the HMD used were reported (e.g., pinching sensation or pressure on the nose, 
sliding off the nose) in < 25% of participants.  There were no complaints of discomfort 
relative to the positioning or weight of the backpack and computer. On item 25 of the 
Presence Questionnaire (Witman & Singer, 1999), participants were asked to rate from 1 
to 7 how distracting the control mechanism (i.e., the HMD, backpack, laptop) was with 1 
being not distracting and 7 being very distracting. The mean response was 2.9/7 (±	  1.7). 
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As implementation of this system continued, there were some patient characteristics that 
became exclusion criteria as they prevented an effective experience of the IAR 
environments. These included cognitive impairment, postural issues (specifically, a 
“stooped” posture), and excess movement issues such as tremor or dyskinesias.  
4.3 IAR Protocol 
Three scenes were developed: a living room, a cereal aisle, and a street crossing, in which 
specific tasks were completed. 
4.3.1 Living Room Scene 
Results from the reach task in the IAR and RW environment are shown in figure 4.1. A 
2x2x3 multivariate analysis of variance was applied to the reach task data with group (PD 
or control), environment (IAR or RW), and visit number (one, two, or three) as 
independent variables and anterior reach limit as the dependent variable. Box’s M test of 
equality of covariance was not violated, however the p value was low (p = 0.006), 
therefore Pillai’s Trace F value will be reported where applicable as it is considered to be 
more conservative. Mauchley’s test of sphericity was violated for the visit effect and 
therefore the Greenhouse-Geisser values will be reported here where applicable.  
There was a significant effect of group (F(1, 31) = 4.980, p = 0.033, η2p = 0.138) on the 
range of motion limits in both the plant watering and reach tasks such that control 
participants had a greater anterior reach limit (87.33 ± 12.21 cm for PD and 93.71 ± 
11.96 cm for the control group).  No other movement limits measured in the functional 
reach test were compared as only forward reaching was performed in the IAR condition.  
There was a significant effect of environment condition (Pillai’s F(1, 31) = 98.519, p < 
0.001, η2p = 0.761) such that participants reached further in the RW condition (82.87 ± 
11.90 cm in the IAR environment and 96.04 ± 9.11 cm in the RW environment). There 
was also a univariate effect of visit number (Greenhouse-Geisser F(1.689, 52.360) = 
3.603, p = 0.041, η2p = 0.104) such that a longer reach was achieved with successive 
visits (87.23 ± 14.42 cm for visit 1, 90.07 ± 11.67 cm for visit 2, and 91.07 ± 10.89 cm 
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for visit 3). A polynomial contrast was statistically significant for a linear effect of visit 
number and a least-significant difference (LSD) post-hoc test revealed there was a 
statistically significant difference between visit one and visit three (mean difference = 
3.45 ± 1.47 cm, p = 0.025).  
 
Figure 4.3.1. Results from reach task. In the immersive augmented reality (IAR) 
environment, participants were asked to keep both feet on the ground and “water” the 
plant furthest from them by bending at the waist. There was a significant effect of group 
(Parkinson disease (PD) compared to controls) (F(1, 31) = 4.980, p = 0.033, η2p = 0.138), 
environment condition (real world (RW) versus IAR environment) (Pillai’s F(1, 31) = 
98.519, p < .001, η2p = 0.761), and visit number (Greenhouse-Geisser F(1.689, 52.360) = 
3.603, p = 0.041, η2p = 0.104). Error bars represent standard error. 
4.3.2 Cereal Aisle Scene  
Data from the grocery store task are presented in figure 4.2. A 2x2x3 multivariate 
analysis of variance was applied to the grocery store scene task with group (PD or 
control), environment (IAR or RW), and visit number (one , two, or three) as independent 
variables and time to complete the task and accuracy of baskets filled as the dependent 
variables. There was a within subjects multivariate effect of condition (Pillai’s Trace F(2, 
28) = 19.323, p < 0.05, η2 = 0.58), of visit (Pillai’s Trace F(4, 116) = 3.371, p < 0.05, η2 = 
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0.208), and a within subjects multivariate condition x visit interaction (Pillai’s Trace F(4, 
116) = 4.487, p < 0.002, η2 = 0.265). 
There was no significant multivariate effect of group. However, there was a significant 
univariate effect of group on time (F(1,29) = 5.543, p = 0.026, η2p = 0.160), but not 
accuracy for this task.  
There was a univariate effect of condition on time (Greenhouse-Geisser F(1, 29) = 
31.356, p < 0.05, η2p = 0.520) and accuracy (Greenhouse-Geisser F(1, 29) = 6.919, p = 
0.014 η2p = 0.193). There was a univariate condition*group interaction effect on 
accuracy of basket filling order (Greenhouse-Geisser F(1, 29) = 4.308, p = 0.047, η2p = 
0.129). There was a univariate condition*visit interaction effect on time (Greenhouse-
Geisser F(1.272, 36.889) = 8.562, p = 0.003, η2p = 0.228) and accuracy (Greenhouse-
Geisser F(1.535, 44.528) = 4.250, p = 0.029, η2p = .0128), where both polynomial 
contrasts were statistically significant for a linear effect.   
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Figure 4.3.2. Results from cereal aisle task. Time to complete the trial in seconds (a) 
and accuracy of filling the baskets (b). Participants were given a sequence of the digits 1 
through 5 that they were required to remember. They were instructed to place a cereal 
box into 5 bins around the room in the same order they were given at the beginning of 
each trial.  There was a multivariate effect of condition (Pillai’s F(2, 28) = 19.323, p < 
0.05, η2 = 0.58), of visit (Pillai’s Trace F(4, 116) = 3.371, p < 0.05, η2 = 0.208), and a 
within subjects multivariate condition x visit interaction (Pillai’s Trace F(4, 116) = 4.487, 
p < 0.002, η2 = 0.265). Error bars represent one standard error.  
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4.3.3 Street Crossing Scene 
Data from the street-crossing scene are presented in figure 4.3.3. A 2x2x3 multivariate 
analysis of variance was applied to the grocery store scene task with group (PD or 
control), environment (IAR or RW), and visit number (one, two, or three) as independent 
variables and time to cross the street at the participant’s “normal, comfortable pace” was 
the dependent measure. Box’s M test of covariance equality was not violated however the 
p value was low; therefore Pillai’s trace F is reported where applicable. There was a 
multivariate main effect of condition (Pillai’s F(1, 31) = 18.389, p < 0.05, η2p = 0.372) 
and visit (Pillai’s F(2, 30) = 3.995, p = 0.029, η2p = 0.210); however there was a 
multivariate condition*visit interaction effect (F(2, 30) = 0.020, η2p = 0.229).  
There was a between-subjects main effect of group (F(1, 31) = 6.311, p =0 .017, η2p = 
0.169), such that the control group completed the task faster.  
Mauchley’s test of sphericity was significant, indicating the sphericity assumption was 
violated. Therefore the Greenhouse-Geisser F values will be reported for the within-
subjects effects where applicable. There was also a within-subjects effect of condition 
(Greehouse-Geisser F(1, 31) = 18.389, p < 0.05, η2p = 0.372) and visit (Greenhouse-
Geisser F(1.201, 37.229) = 6.371, p = 0.012, η2p = 0.170) as well as a condition*visit 
interaction (Greenhouse-Geisser F(1.367, 42.383) = 6.996, p = 0.012, η2p = 0.184).  Tests 
of within-subjects polynomial contrasts for the visit and condition*visit interaction were 
statistically significant for both linear and quadratic effects.  
To parse the condition*visit interaction Bonferroni-adjusted pairwise T-tests were 
applied. These pairwise tests revealed a significant difference between visit 1 & 2 (T = 
3.081, p = 0.013) and visit 1 & 3 (T = 2.655, p = 0.037) in the IAR environment only.  
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Figure 4.3.3. Data from street walking task. Participants were asked to walk at their 
“regular, comfortable pace”. Time to complete the task was recorded. There was a 
between-subjects main effect of group (F(1, 31) = 6.311, p =0 .017, η2p = 0.169), such 
that the control group completed the task faster. There was a main effect of condition 
(Pillai’s F(1, 31) = 18.389, p < 0.05, η2p = 0.372) and visit (Pillai’s F(2, 30) = 3.995, p = 
0.029, η2p = 0.210); however there was a multivariate condition*visit interaction effect 
(F(2, 30) = 0.020, η2p = 0.229). 
4.4 Presence Questionnaire 
Results from the Presence Questionnaire are in Figure 4.4. A 2x3 repeated measures 
analysis of variance was applied to the presence questionnaire scores. There was a 
significant main effect of group (Pillai’s F(1, 31) = 5.683, p = .023, η2p = 0.198) such that 
the control group had a statistically higher score (171.85 ± 11.49) than the PD group 
(156.73 ± 21.52). The maximum score for this questionnaire is 231 (33 questions each 
with a score of 1 to 7 points). A higher score indicates a higher level of presence.  
42 
 
 
Figure 4.4.1. Presence questionnaire scores. There is a significant effect of group 
(Pillai’s F(1, 31) = 5.683, p = .023, η2p = 0.198), but not visit number. No interaction 
effects.  
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Chapter 5  
5 Discussion 
A pilot immersive augmented reality (IAR) software program was developed using open 
access software to successfully simulate three distinct scenes Performances in the IAR 
condition were compared to the performance of analogous tasks in the RW condition in 
an attempt to understand if and how the IAR simulation might affect or alter movement 
in both PD and control participants.  
The results will be discussed under three main headings: the implementation of the 
immersive augmented reality (IAR) system, the IAR tasks, and the presence 
questionnaire results.  
5.1 Implementation of IAR System  
Three scenes were successfully developed and implemented in a single hazard-free real-
world open space. The ability to flexibly apply different virtual environments is a key 
benefit to applying this technology in a rehabilitative setting. Three environments 
commonly encountered by community dwelling adults are living rooms in the home, 
street crossings, and grocery stores in the community. Although these were generic 
scenes, there is potential to customize each of these environments to the specific homes, 
streets, and stores of any individual participant. Evidently, a virtual reality-based system 
is highly flexible and customizable.  
A series of tasks were successfully implemented and completed in a safe environment. 
Although the user perceived various environments with numerous obstacles and objects 
nearby, the physical space was actually clear of any tripping or falling hazards. For this 
reason, a virtual environment may actually be considered as more safe than practicing 
rehabilitative techniques in real world settings as they may also present real world 
dangers.  
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With the ability to simulate real world scenes, movement strategies specific and 
functionally relevant to the user may be learned and practiced. Rather than completing 
simple exercises in a rehabilitation clinic, a participant could perceive they are actually 
going grocery shopping and practice movement and cognitive strategies to facilitate this 
task in the real world.  
5.2 IAR Tasks 
5.2.1 Living Room  
In the simulated living room, a plant-watering task was designed to mimic an established 
measure of balance and range of motion, the Reach Test (Newton, 2001). As would have 
been predicted, the control group had a greater limit of motion than the PD group as 
shown in figure 4.1. This is most likely due to the typical symptoms of PD such as 
rigidity or bradykinesia and is not surprising. The lower CB&M scores relative to the 
control group reflect the physical balance deficits and the ABC scores reflect the 
decreased balance confidence of this PD group. Therefore, the PD participants may have 
experienced a greater sense of imbalance and reduced stability resulting in the shorter 
reach scores. It is well-known that people living with PD have serious balance and 
stability issues (Mak, et al, 2009) but with specific instruction and practice, effective 
strategies can be adopted to manage these symptoms and reduce the risk of falling 
(Mirelman et al., 2011). Therefore it is a suitable target for rehabilitative intervention.  
There was a significant effect of environment such that both the PD and control groups 
reached further in the RW condition. This indicates that both groups perform differently 
depending on the environmental condition. A limited range of motion in the IAR 
environment may be expected, since it was an unfamiliar experience and setting. There 
was also a main effect of visit indicating that performance changed across the three visits 
such that all participants reached further in subsequent visits. This confirms that in this 
task participants have a capacity for improving performance with successive visits, which 
may indicate both increasing comfort and balance confidence in the virtual environment. 
This suggests a familiarization period or a number of familiarization exposures to an IAR 
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system may be valuable to improve comfort (and performance) within this type of 
environment. 
 The data shows an environment*visit interaction that approaches significance. 
Although not significant, it is interesting to briefly consider this effect. This interaction 
suggests that the change in performance across visits may have been different in the RW 
and IAR conditions. Although the watering task is very simple, the added challenge 
provided by the VR system makes it more difficult and allows for an improvement in 
performance across time whereas the RW reach test results in a maximal performance 
from the first visit. In terms of a rehabilitation setting, even for such a simple task, this 
added challenge may actually be beneficial. 
5.2.2 Cereal Aisle Scene  
In the cereal aisle scene, a simple verbal working memory task was combined with free 
walking to challenge participants’ dual-tasking abilities. Several published studies report 
working memory deficits (Siegart, et al., 2008) and dual-tasking difficulties (Wild, et al., 
2012) in PD samples.  
There was a significant difference between the PD and control groups for the multivariate 
effect in this task. This should not be surprising. The test for between-subjects revealed a 
main effect of group on time to complete the trial only, and not on the accuracy scores for 
the order in which the baskets were filled. The effect of group on time to complete the 
trial is an expected finding because of the classical PD symptoms exhibited by the PD 
group including slowness of gait. Our previous work (not published, under review) has 
shown that PD will allocate substantial attentional resources to a secondary cognitive 
task, possibly at the expense of ensuring safe and stable gait patterns. The increased 
attention to the working memory task may also explain why there was no significant 
difference between the PD and control groups in accurately filling the baskets in the 
instructed order. An alternative explanation would be the simplicity of the 5-item 
numerical working memory task. The sample in this study was cognitively intact; 
therefore remembering a series of numbers from 1-5 may have not presented enough of a 
challenge.  
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There was a significant multivariate effect of environment*condition, however there was 
also an environment*visit interaction. Therefore the effect of environment condition will 
not be further discussed outside of the interaction with visit number.  This interaction is 
indicative of differing motor performance in the virtual environment compared to the RW 
environment, depending on the visit number and vice versa.  
The univariate effect of the environment condition*visit interaction was significant for 
both the time and accuracy dependent variables. This suggests that participants were able 
to improve both the time required to complete the task and their accuracy in the IAR 
environment over their three visits. This reinforces the point earlier stated that virtual 
reality systems present an initial challenge that allow room for learning strategies to 
improve performance with practice.  
There was also a univariate environment*group interaction effect on accuracy of the 
order the baskets were filled. This suggests that the PD group is more affected by the IAR 
environment than the control group for accuracy. Although there was not a main effect of 
group on accuracy of this task, it is not surprising that the IAR environment would have a 
greater effect on the PD group. People with PD have difficulty focusing on the most 
relevant sensory information in a given environment (Lee, Cowan, Vogel, Rolan, Valle-
Inclan & Hackley, 2010). With the addition of a virtual system, this may have 
“overloaded” the sensory information and somewhat distracted the patients from the 
working memory task, resulting in an effect on the ability of the PD group to accurately 
fill the grocery baskets.   
5.2.3 Street Crossing Scene  
A street crossing scene was developed in order to create a realistic scenario where tasks 
may be implemented to address some of the issues involved with completing daily tasks 
(Richard, et al., 2004). Participants were asked to walk at their “normal, comfortable 
pace”.  
There was a main effect for all three independent variables: group, visit number, and 
environment condition in this task. The effect of group is again expected as it has been 
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reported numerous times that people with PD walk at a lower velocity than age-matched 
controls (Frankel-Toledo, et al., 2005). 
There was also a condition*visit interaction, therefore the environment condition and 
visit number effects will only be discussed in the context of their interaction and not as 
separate effects. This interaction effect was shown to be composed of the significant 
difference between visits 1 & 2 and 1 & 3 in the IAR environment. This is again 
supportive of IAR in a rehabilitative setting as it presents a sensorimotor challenge that 
also affords improvement with practice.   
5.3 Presence Questionnaire 
A presence questionnaire (appendix J) was administered to measure the subjective 
experience of the virtual environment with respect to the level of presence experienced 
by the participants. Presence has been shown to influence the effectiveness of a virtual 
reality system. For this reason, it was imperative to collect some measure of the 
subjective experience of the participants. Interestingly, the control group scored 
significantly higher than the PD group. According to Witman & Singer (1998), 
“immersion depends on perceiving oneself as a part of the VE stimulus flow”, where 
stimulus flow includes all available sensory information and events that influence and are 
influenced by the user’s actions. It is well-known that people with PD have sensory 
integration issues (Lewis & Byblow, 2002) so by the given definition, it may be 
reasonable to conclude that the PD group experienced less presence due to their 
decreased ability to perceive all stimuli presented in an appropriate way. Similarly, 
people with PD are unable to appropriately filter incoming sensory information and tend 
to pay more attention to functionally irrelevant sensory information, which results in an 
inaccurate perception of their surrounding environment. The discrepancy in the presence 
Q scores between the two participant groups may reflect this deficit. The environments 
presented in the virtual scenes were detailed to appear as realistic as possible and 
therefore were full of sensory cues. Additional sensory information was provided from 
the virtual reality system components (i.e., the weight and feel of the backpack and 
goggles). An inability to “filter out” non-relevant sensory information contributes to the 
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sensory integration issues in PD. While the control group may have been able to 
effectively “ignore” the distraction of the equipment, this additional sensory input may 
have prevented the PD participants from experiencing the same presence level as the 
control group.  
The next step to improve the presence scores in general (i.e., for all participants) would 
be to increase the rate of visual update, improve the viewing angle and make the display 
more realistic in color and sound. This would help the virtual environment appear even 
more realistic and coincide more closely with the user’s rapid head movements. New 
programming using the latest full-surround visor technology is underway in order to 
create even more realistic scenes. New visors are also to be implemented that prevent any 
peripheral view of the real world which will also greatly improve presence. The rate at 
which such new technology is becoming available is high, making it difficult to 
implement and then report the most recent technologies before a new advancement 
becomes available.  
A solution to the reduced presence scores of the PD group may be to limit the amount of 
sensory information available within their visual field. A benefit of systematically 
constructing the virtual scenes is that every detail is meticulously controlled. Versions of 
a scene with simplified sensory input may facilitate a higher level of presence by 
allowing participants to accurately perceive the environment, allowing them to believe 
that they are part of the virtual scene. 
5.4 Overall Conclusions, Limitations and Future Directions 
5.4.1 Conclusions 
Virtual reality technology has the potential to be adaptable to any individual’s particular 
needs while minimizing hazards typically present in daily environments. As this thesis 
has explained, IAR may be useful for the needs of physical rehabilitation. It is flexible, 
customizable, safe, and can be created at an affordable cost.  
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A novel and affordable IAR system was designed and implemented in a sample of people 
living with PD and healthy older adults. Simple tasks were successfully implemented and 
simple quantitative measures of performance were collected.  
Participants’ performance often improved with repeated exposure to the system. This was 
interpreted as familiarization to the IAR system and to the tasks that continued across 
several visits. Therefore it is important to include a sufficient period for acclimatization 
to a virtual system prior to measuring performance gains.  
The IAR approach allows control over: the level of sensory stimuli provided by the 
environment, attentional demands, and cognitive load, which can be varied to challenge 
the participant. Together, this will challenge the cognitive-motor interface that is 
compromised in PD.  
The virtual environment can be constructed with increasing levels of complexity and 
sensory inputs in order to retrain how the patient responds to various manipulations. 
When implemented within a rehabilitation environment, this is an ideal tool for 
sequential learning. Functional tasks in simulated everyday environments can be 
developed with varying levels of difficulty. This is precisely how a virtual rehabilitation 
program can be tailored to the abilities of each individual patient. For example, 
strategically increasing or limiting extraneous details, and decreasing or emphasizing 
critical sensory information can challenge and “train” the system to be more efficient 
with incoming stimuli.  By learning new strategies to manage the symptoms of PD in 
order to complete ADLs, quality of life and independence may be maintained.  
This pilot testing of an IAR system has confirmed the viability of this type of system for 
scientific investigation of clinical populations and has demonstrated potential within the 
rehabilitation world. Indeed, this approach can be seen as an enhanced and practical 
version of occupational and physical therapy intervention. 
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5.4.2 Limitations 
 The results presented throughout this thesis suggest that IAR has great potential 
for successful implementation in rehabilitation settings. However, the technology 
implemented in this first round of testing requires some modification to improve the level 
of presence experienced by the user. As stated by Witmer and Singer (1999), “presence is 
an indispensable contributor to the effectiveness of a virtual system.” The graphical 
programming for this project must be upgraded for future use. A less than optimal level 
of presence may have contributed to any learning effects that were observed (i.e., the 
effect of visit number).  
 All tasks were first completed in the IAR environment and subsequently 
completed in the real world. This was initially done to avoid learning in the real world 
tasks that may carry over to the IAR performance in order to identify the effect of the 
system on performance. However, this may have affected the results as performance in 
the real world may be partially due to a learning effect from first completing the task in 
the IAR environment. Future studies of a similar nature should randomize and alternate 
the order of environments in which the tasks are completed.  
 The control group in this study was half the size of the PD sample. This may have 
skewed some results. Future studies should aim for a larger and equal size of groups.  
5.4.3 Future Directions 
 The purpose of this study was to confirm the tolerability and viability of this 
technology for rehabilitation purposes in a clinical population. For this reason, 
deliberately simple tasks were implemented that do not necessarily have direct functional 
relevance to real world activities of daily living. Future studies will implement more 
complex and realistic tasks.  
 This study was designed to quantify the change in performance over a series of 
three weekly visits. For this reason, the same protocol with the same tasks was completed 
at each visit. Future studies will include both more frequent training sessions and over a 
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longer duration (e.g., 6 to 12 weeks). Additionally, the program will adhere to more 
rehabilitative “training” methods and will quantify translational benefit from the program 
to daily tasks. For example, participants will complete a number of simple everyday 
tasks, such as going grocery shopping or preparing a meal, and will then complete a 
training program within the IAR environment designed to facilitate these everyday tasks. 
To measure translational benefit, the same tasks performed prior to the training will be 
completed and any gain in performance may be quantified.  
As previously mentioned, there is room for improvement with respect to the 
programming as well as the technological aspects of this system. New visor technology 
has already been purchased and the next stage of programming is underway. These 
advancements are promising and will improve the experience of presence and the overall 
delivery of the virtual environment. Together, this will substantially improve the 
effectiveness, applicability and viability of the IAR system as a rehabilitation tool.  
Presence is a critical component to the effectiveness of a virtual reality program. For this 
reason, future work should investigate novel techniques for increasing the level of 
presence experienced by PD. For example, strategically limiting extraneous details, or 
emphasizing critical sensory information to challenge and “train” the system to be more 
efficient with incoming stimuli.  The sensory deficits inherent to this population require a 
flexible and dynamic approach to the software development process. 
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Appendices 
Appendix A: Inclusion/Exclusion	  Criteria 
Inclusion criteria were: 1) diagnosis of idiopathic PD Hoehn & Yahr stage 2-3 to limit 
disease severity thereby reducing confounding factors of dementia or motor involvement 
impacting testing; 2) stable PD management (have been a clinic patient for 12 months 
prior to enrollment) with no change in medication during the study; 3) minimum grade 10 
education to reduce education variance as a factor on test performance; 4) between the 
ages of 40 and 80 years old to reduce any confounding aging effects; 5) no significant 
wearing off or fluctuations between medication doses as cognitive fluctuations can be a 
component of wearing off; 6) no other neurological disease to prevent any confounding 
results as a result of a co-morbidity, specifically stroke, seizure disorder, brain tumor, 
head injury, spinal cord injury or severe peripheral neuropathy; 7) no other injuries or 
illness that may impair motor function such as recent fractures, dislocations, artificial 
limbs, recent surgical procedures or any injury or illness requiring a brace or walking aid; 
8) no other psychiatric illness that may affect motor or cognitive performance.  
Exclusion criteria were: 1) freezing of gait or other severe gait symptoms as this could 
present an unnecessary risk in an unfamiliar environment; 2) on- or off-state dyskinesia 
because the current technology of the visor causes a timelag that is amplified with 
dyskinetic movements; 3) a Montreal Cognitive Assessment score less than 20 since 
cognitive performance will be measured and substantial cognitive decline may skew the 
results; and 4) any neuro-opthamological condition or pathology that may affect 
performance, specifically convergence deficiencies and oculomotor abnormalities as 
determined by a neuro-opthamologist.    
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Appendix B: The	  Activities-­‐Specific	  Balance	  Confidence	  Scale 
The Activities-specific Balance Confidence (ABC) scale was created by Powell & Myers 
(1995) and has been validated for assessing balance confidence while performing a 
variety of functional activities in the elderly. This paper-based scale takes approximately 
ten minutes to complete. Participants are asked, “For each of the following, please 
indicate your level of confidence in doing the activity without losing your balance or 
becoming unsteady by choosing one of the percentage points on the scale from 0% (no 
confidence) to 100% (complete confidence).” If the participant does not do a particular 
activity, they are asked to imagine how confident they would be if they had to do the 
activity. Examples include walking around the house or walking on icy sidewalks. The 
sum of the ratings for all tasks (possible range from 0-1600) is divided by 16 to obtain the 
ABC score. Patients with a score below 75.6 are at risk for falls (Landers MR, Backlund 
A, Davenport J, Fortune J, Schuerman S, Altenburger P. Postural instability in idiopathic 
Parkinson’s disease: discriminating fallers from nonfallers based on stan- dardized 
clinical measures. J Neurol Phys Ther. 2008;32:56-61). The ABC has a test-retest 
reliability r = 0.92 (p<.001) in community dwelling elders (Powell & Myers, 1995) and 
internal consistency of 0.85 (95% CI, .68-.93) in community dwelling adults with stroke 
(Botner & Miller, 2005). No reliability scores have been reported specifically in a PD 
sample. The ABC has acceptable construct validity as scores have been significantly 
correlated with many other measures. ABC scores have shown weak correlations with 
older age (r = - .23), longer Timed-Up-and-Go time (r = -.39), greater activity restriction 
(r = -.43), higher Geriatric Depression Scale score (r = -.38), more falls in the previous 
year (r = -.20), a greater number of chronic illnesses (r = -.32), and moderate correlations 
with lower Berg Balance Test score (r = .57), slower gait speed (r = .51), assistive device 
use (r = .51), (p<.001 for all values) (Talley, Wyman & Gross, 2008). 
The ABC also has reported concurrent validity with moderate positive, linear correlation 
between the ABC total score and the Berg Balance Test score using Spearman’s 
correlation coefficient, r = 0.36, p<0.001; and moderate, positive linear correlation 
between the ABC total score and gait speed, r =0.48, p<0.001 (Botner & Miller, 1995). 
Finally there is also indication for discriminative/predictive validity: A score < 67% 
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identifies fallers from non- fallers, with 84% sensitivity and 87% specificity in older 
people living in the community (Lajoie & Gallagher, 2004).  
The ABC was administered to both the PD and control groups at the initial visit, prior to 
any experimental tasks.  
The Activities-specific Balance Confidence (ABC) Scale* 
Instructions to Participants: 
For each of the following, please indicate your level of confidence in doing the activity 
without losing your balance or becoming unsteady from choosing one of the percentage 
points on the scale form 0% to 100%. If you do not currently do the activity in question, 
try and imagine how confident you would be if you had to do the activity. If you 
normally use a walking aid to do the activity or hold onto someone, rate your confidence 
as it you were using these supports. If you have any questions about answering any of 
these items, please ask the administrator. 
The Activities-specific Balance Confidence (ABC) Scale* 
For each of the following activities, please indicate your level of self- confidence by 
choosing a corresponding number from the following rating scale: 
0% 10 20 30 40 50 60 70 80 90 100% no confidence completely confident 
“How confident are you that you will not lose your balance or become unsteady when 
you... 
1. ...walk around the house? ____%  
2. ...walk up or down stairs? ____%  
3. ...bend over and pick up a slipper from the front of a closet floor ____%  
4. ...reach for a small can off a shelf at eye level? ____%  
5. ...stand on your tiptoes and reach for something above your head? ____%  
6. ...stand on a chair and reach for something? ____%  
7. ...sweep the floor? ____%  
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8. ...walk outside the house to a car parked in the driveway? ____%  
9. ...get into or out of a car? ____%  
10. ...walk across a parking lot to the mall? ____%  
11. ...walk up or down a ramp? ____%  
12. ...walk in a crowded mall where people rapidly walk past you? ____%  
13. ...are bumped into by people as you walk through the mall?____%  
14. ... step onto or off an escalator while you are holding onto a railing? ____%  
15. ... step onto or off an escalator while holding onto parcels such that you cannot 
hold onto the railing? ____%  
16. ...walk outside on icy sidewalks? ____% 
  
*Powell, LE & Myers AM. The Activities-specific Balance Confidence (ABC) Scale. J 
Gerontol Med Sci 1995; 50(1): M28-34 
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Appendix C: Parkinson	  Disease	  Questionnaire-­‐8 The	  paper-­‐based	  8-­‐item	  Parkinson	  Disease	  	  Questionnaire	  (PDQ-­‐8)	  is	  a	  shortened	  version	  of	  the	  original	  39-­‐item	  quality	  of	  life	  questionnaire,	  both	  developed	  by	  Peto,	  Jenkinson	  &	  Fitzpatrick	  (1998)	  to	  obtain	  information	  about	  self-­‐perceived	  health	  in	  PD.	  The	  PDQ-­‐39	  was	  designed	  to	  obtain	  a	  score	  for	  8	  dimensions	  (e.g.,	  mobility,	  activities	  of	  daily	  living,	  emotional	  well-­‐being,	  etc,)	  through	  a	  number	  of	  questions.	  The	  item	  most	  highly	  correlated	  with	  each	  dimension	  score	  was	  used	  to	  construct	  the	  PDQ-­‐8.	  This	  scale	  is	  completed	  by	  the	  participants	  and	  the	  items	  ask	  the	  participant	  to	  consider	  how	  often	  in	  the	  last	  month	  they	  have	  experienced	  certain	  events	  (e.g.	  had	  difficulty	  getting	  around	  in	  public?)	  and	  to	  indicate	  the	  frequency	  of	  each	  event	  by	  selecting	  one	  of	  5	  options	  (likert	  Scale):	  never/occasionally/sometimes/	  often/always	  or	  cannot	  do	  at	  all	  which	  are	  each	  scored	  0-­‐4	  respectively.	  The	  score	  for	  the	  PDQ-­‐8	  is	  a	  percentage	  of	  the	  thirty-­‐two	  point	  maximum	  (i.e.,	  the	  sum	  of	  scores	  for	  all	  questions	  is	  divided	  by	  32	  and	  multiplied	  by	  one	  hundred).	  	  The	  PDQ-­‐39	  is	  accepted	  to	  be	  a	  valid	  and	  reliable	  tool	  (Jenkinson,	  1998).	  The	  PDQ-­‐39	  and	  PDQ-­‐8	  scores	  are	  highly	  correlated	  (r	  =	  0.96,	  p	  <	  0.001,	  n	  =	  459).	  In	  the	  initial	  validation	  study	  of	  this	  scale,	  the	  mean	  PDQ-­‐8	  index	  score	  was	  47.25	  (SD	  =	  20.96,	  min	  =	  0,	  max	  =	  100,	  n	  =	  543;	  95%	  CI	  =	  45.5-­‐49.0).	  The	  25th,	  50th	  and	  75th	  percentile	  scores	  were	  calculated	  which	  were	  31.25,	  50.00	  and	  62.50	  (n=543),	  respectively.	  The	  data	  was	  divided	  by	  clinician	  Hoehn	  and	  Yahr	  staging	  and	  produced	  the	  following	  benchmarks:	  stage	  1	  mean	  =	  17.74	  (SD	  =	  16.27),	  stage	  II	  mean	  =	  33.14	  (SD	  =	  18.80),	  stage	  III	  mean	  =	  37.05	  (SD	  =	  22.05),	  Stage	  IV,	  V	  mean	  =	  47.86	  (SD	  =	  16.17).	  	  	  The	  authors	  claim	  construct	  validity	  is	  high	  as	  the	  original	  items	  were	  generated	  from	  exploratory	  in-­‐depth	  interviews	  with	  patients.	  Cronbach’s	  alpha	  statistic	  for	  internal	  reliability	  in	  Canada	  was	  found	  to	  be	  0.83	  (Jenkinson	  &	  Fitzpatrick,	  2007).	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The	  PDQ	  is	  designed	  specifically	  for	  people	  with	  PD,	  and	  was	  included	  in	  the	  study	  protocol	  as	  a	  proxy	  for	  disease	  severity	  from	  the	  patient’s	  point	  of	  view.	  The	  PDQ-­‐8	  index	  score	  was	  included	  to	  comprise	  part	  of	  the	  motor	  profile	  score	  of	  each	  participant.	  For	  these	  reasons	  it	  was	  administered	  to	  the	  PD	  group	  only,	  and	  not	  the	  control	  group.	  	  
PDQ 8 – Parkinson’s Disease Quality of Life 
Questionnaire 
DUE TO HAVING PARKINSON’S DISEASE, how often have you 
experienced the following, during the last month? 
 
Due to having Parkinson’s disease,  
how often during the last month  
have you…. 
Please tick one box for each question 
 
          Never    Occasionally  Sometimes  Often   Always 
            or cannot do at all 
1. Had difficulty getting  
around in public? 
     
2. Had difficulty dressing 
yourself? 
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3. Felt depressed? 
 
     
4. Had problems with your 
close personal relationships? 
     
5. Had problems with your 
concentration, i.e. when 
reading of watching tv? 
     
6. Felt unable to communicate 
with people properly? 
     
7. Had painful muscle cramps 
or spasm? 
     
8. Felt embarrassed in public 
due to having Parkinson’s 
disease? 
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Appendix D: Montreal	  Cognitive	  Assessment 
Cognitive impairment on neuropsychologic testing is evident in over 20% of Parkinson’s 
disease (PD) patients at the time of diagnosis (Foltynie, 2004; Muslimovi et al., 2005), 
and over 80% of PD patients will develop dementia over an 8 year period (Maxieux et al., 
1998). Some cognitive tests such as the Mini-Mental State Examination (MMSE) 
(Folstein et al., 1975) are insensitive to the cognitive impairments in PD (Marinus et al 
2003) and the length of neuropsychologic batteries is inconvenient for research purposes 
(Biggins et al., 1992). Specifically, the executive and visuospatial function domains are 
known to be affected in early PD (Muslimovic et al., 2005; Mahieux et al., 1998), 
therefore it was imperative to include such a screen prior to enrolling participants in this 
virtual reality paradigm.   
The Montreal Cognitive Assessment (MoCA) (Nasreddine et al., 2005) was developed as 
a screening tool for mild cognitive impairment. The MoCA is a short cognitive screening 
tool that resembles the widely used MMSE, but is more sensitive than the MMSE in 
identifying mild cognitive impairment in the general population. The MoCA takes about 
10 minutes to administer in the general population, therefore was advantageous and 
convenient to include in the study protocol. The MoCA tests several cognitive domains: 
executive and visuo-spatial functioning, memory, language, and attention. Some 
examples of items are the alternating trail making test to assess visual attention and task 
switching, cube copying and clock drawing test to assess visuoconstructional ability, 
identifying line drawings of animals test naming ability, forward and backward digit span 
tests to assess attentional ability, and naming as many words beginning with a particular 
letter within 60 seconds to assess verbal fluency. There are eleven items in total that are 
completed, with increased scoring weight to the items most discriminant of mild 
cognitive impairment. To obtain a score, the total of all items is summed for a maximum 
score of 30. A final score of 26 or above considered normal.  
Gill et al. (2008) conducted a validation study of the MoCA specifically in the PD 
population. The average administration time for the MoCA was 8.1 6 2.1 min. The test–
retest intraclass correlation coefficient was 0.79 (95% CI: 0.36–1.2). Inter-rater reliability 
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testing revealed a mean change in MoCA scores between examiners of 0.6 and the 
intraclass correlation coefficient between examiners was 0.81 (95% CI: 0.41–1.2). The 
correlation coefficient between the MoCA and a neuropsychological battery was 0.72 (p 
< .0001), indicating high construct validity. The scores were divided according to Hoehn 
& Yahr stages I-V: for Stages I–II the average score was 23.3 ± 4.1, for Stage III the 
average score was 21.2 ± 4.8, and for Stages IV–V, the average score was 19.9 ± 4.3. 
These results confirm the MoCA is reliable and valid in the PD population. A copy of the 
MoCA is below.   
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Appendix E: Community	  Balance	  and	  Mobility	  Scale	  
The Community Balance and Mobility (CB&M) scale was developed at the University of 
Toronto to evaluate balance and mobility in patients who are ambulatory and functioning 
at a high level, yet who have persistent balance problems. Due to the nature of this 
protocol, the sample included was fully ambulatory and without excessive risk of falling. 
For this reason typical tests of balance such as the Berg Balance test might not have been 
sensitive enough to identify the true balance limits of the participants or to distinguish 
between these high-functioning patients and the control group. The items of the CB&M 
encompass challenging balance and mobility tasks and are therefore useful in a fully 
ambulatory sample.  
There are 13 various tasks within the CB&M and six are performed on the left and right 
side, resulting in a total of 19 tasks. Some examples are tandem walking, unilateral 
stance, descending stairs, crouch and walk, hopping forward, and lateral foot “scooting”. 
Each task is scored from 0-5 with detailed grading instructions. One item (descending 
stairs) has an additional point awarded to those who can complete the task carrying a 
laundry basket. Therefore, the highest possible score of the CB&M is 96. 
The CB&M was initially created for use in patients with traumatic brain injury as balance 
is a persistent symptom long after the initial injury even after patients have regained 
many other functions. There have not been validation studies done for this test 
specifically in PD, however it has been extensively validated by Howe et al (2005) in 
brain injury patients. In the original validation study, content validity was ensured by 
including items only identified by practicing physical therapists as functionally relevant 
to measuring balance ability. Furthermore, the CB&M scores were correlated with global 
balance ratings (a 5-point questionnaire about self-perceived balance) completed by both 
the physical therapists at r = 0.62 (p < 0.001) the patients at r = 0.39 (p = 0.023).  
The CB&M was found to have acceptable construct validity by correlated the CB&M 
scores with other measures of balance ability here was a significant correlation with self-
paced and maximal gait velocity at r = 0.53 (p < 0.001) and r = 0. 64 (p < 0.001), 
respectively.  
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Intraclass correlation coefficient (ICC) for intra-rater reliability was 0.977 (95% CI: 
0.957-0.986), for inter-rater reliability was 0.977 (95% CI: 0.972-0.988), for immediate 
test-retest reliability was 0.975 (95% CI: 0.810-0.991), and for test-retest reliability 5 
days apart was 0.898 (95% CI: 0.624-0.953).   
Internal consistency was evaluated within both validity and reliability with a Cronbach’s 
alpha of 0.96 and 0.95, respectively, suggesting that the items correlate highly and reflect 
the same construct. 
The positive results support the CB&M as a useful clinical outcome measure to evaluate 
balance in the higher functioning, ambulatory patient. The authors also state that “clinical 
feedback and preliminary evidence indicates that the scale is also appropriate for clients 
with diagnoses other than traumatic brain injury” further indicating that this scale was 
appropriate for the IAR protocol. A copy of the CB&M is below. 
COMMUNITY BALANCE & MOBILITY SCALE 
(CB&M) SCORE SHEET        
Participant #: _______ 
Full CB&M guidelines must be reviewed to ensure accurate administration and scoring. 
To score 5, actions must appear coordinated and controlled without excessive equilibrium 
reactions. 
CB&M Tasks Notes Score 
1. UNILATERAL STANCE 
0 unable to sustain 
1 2.00 to 4.49 sec. 
2 4.50 to 9.99 sec. 
3 10.00 to 19.99 sec. 
4 > 20.00 secs. 
5 45.00 sec., steady and coordinated 
 
“Look straight 
ahead” 
 
Left 
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Test is over if stance 
foot moves from start 
position or raised foot 
touches ground. 
Right 
2. TANDEM WALKING 
0 Unable 
1 1 step 
2 2 to 3 consecutive steps (heel-toe distance < 3”) 
3 > 3 consecutive steps (heel-toe distance < 3”) 
4 > 3 consecutive steps(in good alignment = heel-toe contact 
and feet straight  
5 7 consecutive steps 
 
 
 
“Look ahead down 
the 
track, not at your 
feet.” 
 
3. 180° TANDEM PIVOT 
0 unable to sustain tandem stance 
1 sustains tandem stance but unable to unweight heels or 
initiate pivot 
2 initiates pivot but unable to complete 180° turn 
3 completes 180° turn but discontinuous pivot (e.g. pauses on 
toes) 
4 completes 180° turn in a continuous motion but can’t 
sustain reversed position 
5 completes 180° turn in a continuous motion and sustains 
reversed position 
 
 
 
Test is over if 
touches 
heels down or steps 
out 
of position. 
 
4. LATERAL FOOT SCOOTING 
0 unable 
1 1 lateral pivot 
2 2 lateral pivots 
3 > 3 pivots but < 40 cm 
4 40 cm in any fashion and/or unable to control final position 
5 40 cm continuous, rhythmical motion with controlled stop. 
 
 
 
Test is over if patient 
hops or opposite foot 
touches down. 
Left 
 
 
Right 
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5. HOPPING FORWARD 
0 Unable 
1 1 to 2 hops, uncontrolled 
2 2 hops, controlled but unable to complete 1 metre 
3 1 metre in 2 hops but unable to sustain landing (touches 
down) 
4 1 metre in 2 hops but difficulty controlling landing (hops or 
pivots) 
5 1 metre in 2 hops, coordinated with stable landing 
 
 
Test is over if 
opposite 
foot touches down. 
Left 
 
 
Right 
6. CROUCH AND WALK 
0 unable to crouch 
1 able to descend only 
2 descends and rises but hesitates, unable to maintain forward 
momentum 
3 crouches and walks in continuous motion, time < 8.00 sec. 
protective step 
4 crouches and walks in continuous motion, time < 8.00 sec. 
excess equilibrium reaction 
5 crouches and walks in continuous motion, time < 4.00 sec. 
 
  
 
 
 
 
 
 
 
1 CB&M Scale           
 Toronto Rehab / U of T 
7. LATERAL DODGING 
0 unable to perform 1 cross-over in both directions without 
support 
1 1 cross-over in both directions in any fashion 
2 1 or more cycles, but does not contact line every step 
3 2 cycles, contacts line every step 
4 2 cycles, contacts line every step 12.00 to 15.00 sec. 
5 2 cycles, contacts line every step < 12.00 sec. coordinated 
direction change 
 
 
“Do this as fast as 
you 
can yet at a speed 
that 
you feel safe.” 
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8. WALKING & LOOKING 
0 unable to walk and look e.g. stops 
1 performs but loses visual fixation at or before 4 metre mark 
2 performs but loses visual fixation after 4 metre mark 
3 performs and maintains visual fixation between 2-6 metre 
mark but protective step 
4 performs and maintains visual fixation between 2-6 metre 
mark but veers 
5 performs, straight path, steady and coordinated < 7.00 sec. 
 
 
“Walk at your usual 
pace.” 
Left 
 
 
Right 
9. RUNNING WITH CONTROLLED STOP 
0 unable to run 
1 runs, time > 5.00 sec. 
2 runs, time > 3.00 but < 5.00 sec., unable to control stop 
3 runs, time > 3.00 but < 5.00 sec., with controlled stop, both 
feet on line 
4 runs, time < 3.00 sec., unable to control stop 
5 runs, time < 3.00 sec., with controlled stop, both feet on line, 
coordinated 
6 and rhythmical 
 
 
“Run as fast as you 
can.” Hold position 
on 
finish line. 
 
10. FORWARD TO BACKWARD WALKING 
0 unable 
1 performs but must stop to regain balance 
2 performs with reduced speed, time > 11.00 sec. or requires 4 
or more steps 
3 to turn 
4 performs in < 11.00 sec. and/or veers during backward 
walking 
5 performs in < 9.00 sec. and/or uses protective step during or 
just after turn 
6 performs in < 7.00 sec., maintains straight path 
 
 
“Walk as quickly as 
you 
can yet at a speed 
that 
you feel safe.” 
 
11. WALK, LOOK AND CARRY 
 
(Score same as #8 Walking and Looking) 
 
 
“Walk at your usual 
pace.” 
Left 
 
Right 
 
12. DESCENDING STAIRS 
0 0 unable to step down 1 step, or requires railing or assistance 
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1 able to step down 1 step with/without cane (no railing) 
2 able to step down 3 steps with/without cane, any pattern (no 
railing) 
3 3 steps reciprocal or full flight in step-to pattern (no cane, no 
railing) 
4 full flight reciprocal, awkward (no cane, no railing) 
5 full flight reciprocal, rhythmical and coordinated (no cane, no 
railing) 
+1 bonus for carrying basket 
 
13. STEP-UPS X 1 STEP 
0 unable to step up, requires assistance or railing 
1 steps up, requires assistance or railing to descend 
2 steps up and down (1 cycle) (not looking at feet) 
3 completes 5 cycles (not looking at feet) 
4 completes 5 cycles in > 6.00 but < 10.00 sec. (not looking at 
feet) 
5 completes 5 cycles in < 6.00 sec., rhythmical (not looking at 
feet) 
 
 
“Do this as quickly 
as 
you can. Try not to 
look 
at your feet.” 
Left 
 
 
Right 
 
 
TOTAL SCORE: 
 
Toronto Rehab / U of T 
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Appendix F: Unified	  Parkinson	  Disease	  Rating	  Scale	  Items	  
The Unified Parkinson Disease Rating Scale is a commonly used tool to assess people 
living with Parkinson disease. It is divided into several sections: I. Mentation, behavior 
and mood, II. Activities of daily living, III. Motor examination, IV. Complications of 
therapy, V. Modified Hoehn and Yahr Staging, and VI. Schwab and England activities of 
daily living scale. The third section (motor examination) is commonly reported to provide 
an idea of the motor function status of people with PD. 
The following items were reported as part of the participants’ “motor profile”: 
18. Speech 
0 = Normal.  
1 = Slight loss of expression, diction and/or volume.  
2 = Monotone, slurred but understandable; moderately impaired.  
3 = Marked impairment, difficult to understand.  
4 = Unintelligible. 
20. Tremor at rest (head, upper and lower extremities)  
0 = Absent.  
1 = Slight and infrequently present.  
2 = Mild in amplitude and persistent. Or moderate in amplitude, but only 
intermittently present.  
3 = Moderate in amplitude and present most of the time. 
4 = Marked in amplitude and present most of the time. 
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22. Rigidity (Judged on passive movement of major joints with patient relaxed in sitting 
position. Cogwheeling to be ignored.)  
0 = Absent.  
1 = Slight or detectable only when activated by mirror or other movements. 
2 = Mild to moderate.  
3 = Marked, but full range of motion easily achieved.  
4 = Severe, range of motion achieved with difficulty. 
23. Finger Taps (Patient taps thumb with index finger in rapid succession.)  
0 = Normal.  
1 = Mild slowing and/or reduction in amplitude.  
2 = Moderately impaired. Definite and early fatiguing. May have occasional 
arrests in movement.  
3 = Severely impaired. Frequent hesitation in initiating movements or arrests in 
ongoing movement.  
4 = Can barely perform the task. 
24. Hand Movements (Patient opens and closes hands in rapid succesion.)  
0 = Normal.  
1 = Mild slowing and/or reduction in amplitude.  
2 = Moderately impaired. Definite and early fatiguing. May have occasional 
arrests in movement.  
3 = Severely impaired. Frequent hesitation in initiating movements or arrests in 
ongoing movement.  
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4 = Can barely perform the task. 
25. Rapid Alternating Movements of Hands (Pronation-supination movements of hands, 
vertically and horizontally, with as large an amplitude as possible, both hands 
simultaneously.)  
0 = Normal.  
1 = Mild slowing and/or reduction in amplitude. 
2 = Moderately impaired. Definite and early fatiguing. May have occasional 
arrests in movement.  
3 = Severely impaired. Frequent hesitation in initiating movements or arrests in 
ongoing movement.  
4 = Can barely perform the task. 
26. Leg Agility (Patient taps heel on the ground in rapid succession picking up entire leg. 
Amplitude should be at least 3 inches.) 
0 = Normal.  
1 = Mild slowing and/or reduction in amplitude. 
2 = Moderately impaired. Definite and early fatiguing. May have occasional 
arrests in movement.  
3 = Severely impaired. Frequent hesitation in initiating movements or arrests in 
ongoing movement.  
4 = Can barely perform the task. 
29. Gait 
0 = Normal.  
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1 = Walks slowly, may shuffle with short steps, but no festination (hastening 
steps) or propulsion.  
2 = Walks with difficulty, but requires little or no assistance; may have some 
festination, short steps, or propulsion.  
3 = Severe disturbance of gait, requiring assistance.  
4 = Cannot walk at all, even with assistance. 
30. Postural Stability (Response to sudden, strong posterior displacement produced by 
pull on shoulders while patient erect with eyes open and feet slightly apart. Patient is 
prepared.)  
0 = Normal. 
1 = Retropulsion, but recovers unaided. 
2 = Absence of postural response; would fall if not caught by examiner.  
3 = Very unstable, tends to lose balance spontaneously. 
4 = Unable to stand without assistance. 
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Appendix G: Physical	  Space	  
Fiducial marker setup. A total of 110 black and white fiducial markers made of 
corrugated plastic were mounted on the walls and floor. The markers used were unique 
black and white patterns printed on corrugated plastic squares. The chosen patterns 
exhibited high contrast to facilitate detection by the camera system There were five 
different sizes of markers (45 cm2, 30 cm2, 20 cm2, 15 cm2 and 10 cm2); the largest ones 
enabled the camera to track positions from longer distances while the smallest markers 
allowed the user to interact with objects from shorter distances.  
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Appendix H: Hardware	  
 
 
 
 
Hardware: The head mounted display, camera, and light-weight laptop.  
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Participant wearing all hardware (laptop in backpack).   
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Appendix I: Immersive	  Augmented	  Reality	  Scenes	  
 
Living room scene.  
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Living room scene. Participant could see their hand holding a watering can to “water” 
flowers.  
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Cereal aisle scene.  
88 
 
 
Cereal aisle scene.  
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Street crossing scene. 
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Appendix J: Presence	  Questionnaire	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